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Abstract 
High-resolution imaging for cancer detection with a fiber bundle microendoscope 
By 
Timothy J. Muldoon 
Dysplasia and cancer of epithelial tissues* including the oral cavity and 
esophagus, typically have much higher survival rates if diagnosed at an early stage. 
Unfortunately, the clinical appearance of lesions in these tissues can be highly variable. 
To achieve a definitive diagnosis of a suspected lesion at these sites, an excisional biopsy 
must be examined at high-resolution. These procedures can be costly and time-
consuming, and in the case of Barrett's esophagus, surveillance biopsy strategies may not 
be entirely effective. Optical imaging modalities have the potential to yield qualitative 
and quantitative high-resolution data at low cost, enabling clinicians to improve early 
detection rate. 
This dissertation presents a low-cost high-resolution microendoscopy system 
based on a fiber optic bundle image guide. In combination with a topical fluorescent dye, 
the fiber bundle can be placed into contact with the tissue to be observed. A high-
resolution image is then projected onto a CCD camera and stored on a PC. A pilot study 
was performed on both resected esophageal tissue containing intestinal metaplasia (a 
condition known as Barrett's esophagus, which can transform to esophageal 
adenocarcinoma) and resected oral tissue following surgical removal of cancer. 
Qualitative image analysis demonstrated similar features were visible in both 
microendoscope images and standard histology images, and quantitative image 
processing and analysis yielded an objective classification algorithm. 
The classification algorithm was developed to discriminate between neoplastic 
and non-neoplastic imaging sites. The performance of this algorithm was monitored by 
comparing the predicted results to the pathology diagnosis at each measurement site. In 
the oral cancer pilot study, the classifier achieved 85% sensitivity and 78% specificity 
with 141 independent measurement sites. In the Barrett's metaplasia pilot study, 87% 
sensitivity and 85% specificity were achieved with 128 independent measurement sites. 
The work presented in this dissertation outlines the design, testing, and initial 
validation of the high-resolution microendoscope system. This microendoscope system 
has demonstrated potential utility over a wide range of modalities, including small animal 
imaging, molecular-specific imaging, ex vivo and ultimately in vivo imaging. 
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Chapter 1: Introduction 
1.1 Motivation 
In the United States, cancer is second only to heart disease as the leading cause of 
death. There will be nearly 1.4 million estimated new cases of cancer diagnosed in 2006, 
and an estimated 560,000 deaths [1]. Certain types of cancer account for a 
disproportionately high number of these cases; breast cancer and prostate cancer account 
for about 30% of all new cancer diagnoses in women and men respectively. However, 
lung cancer remains the leading cause of cancer mortality. 
Early detection of cancer has been shown to generally have a significant effect on 
survival and quality of life. If cancer can be discovered at an early stage, when the risk 
for metastasis is low, treatment is generally simpler to perform and with less morbidity, 
and survival is improved. In the case of oral cancers, early detection is key: 5-year 
survival for cancers diagnosed as localized to a single area is greater than 80%, while 
survival for oral cancer presenting with distant metastases at diagnosis falls to 25%. 
Esophageal follows a similar pattern, 5-year survival with local disease is 34%, falling to 
just 3% for distant disease. Other types of cancer display a similar trend (Table 1-1) [2]. 
While the need for early diagnosis is clear, there are often many other factors that 
can lead to a delay. Usually, the definitive diagnosis for a suspicious lesion is to remove 
all or part of it for examination by a highly trained pathologist following tissue 
processing. The biopsy procedure itself takes time, but its invasiveness may lead a patient 
or their physician to hesitate. Oral cancers, for example, may often appear as benign 
lesions to an experienced clinician, and often a patient may not even present a problem to 
a physician until the cancer has reached an advanced stage. Barrett's metaplasia, a 
condition caused by chronic reflux and inflammation of the esophagus and characterized 
by replacement of normal squamous epithelium with glandular epithelium, is another 
condition where occult cancer may exist. Surveillance requires endoscopic inspection and 
biopsy of the affected region, usually undersampling the area. Malignant transformation 
to esophageal adenocarcinoma can occur in such patients even with routine standard-of-
care inspection. 
Cancer Site Local Regional Distant 
Breast 
Oral 
Prostate 
Esophagus 
>90% 
>80% 
-100% 
34% 
80% 
50% 
>85% 
17% 
25% 
25% 
30% 
3% 
Table 1-1: Stage at diagnosis and 5-year survival figures 
1.2 Specific Aims 
The overall focus of this project was to develop and evaluate a robust, portable 
imaging system capable of distinguishing between neoplastic and non-neoplastic lesions 
in a variety of epithelial tissues. The following specific aims detail how this project was 
accomplished 
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Specific Aim 1: 
Develop and characterize a high-resolution microendoscope device, based on a 
fiber optic image guide. Confocal microscopy has been the gold standard for high-
resolution imaging within turbid media, such as tissue, but large bulky optics and 
expensive electronics have limited its clinical use to tertiary care centers with extensive 
funding and infrastructure. A fiber optic image guide coupled to a simple fluorescence 
microscope using an LED as an excitation source was developed to address this issue. By 
placing the distal tip of the fiber optic image guide in direct contact with tissue, following 
the application of a fluorescent dye, high-resolution images of the upper surface of tissue 
were attained. This approach is useful clinically since the fiber optic probe can be 
extended to any accessible epithelial or lumenal surface in the body, including the oral 
cavity and esophagus. To characterize the device, a number of in vitro experiments were 
conducted, using non biologic and biologic models of increased complexity, culminating 
with resected human tissue specimens. 
Specific Aim 2: 
We evaluated the performance of the imaging system to discriminate neoplastic 
from non-neoplastic lesions in resected oral cancer specimens. In normal squamous 
tissue, cells are regularly spaced, with small nuclei and small nuclear-to-cytoplasmic 
ratios. In dysplasia and cancer, this architecture changes and becomes more irregular, 
with significantly larger nuclear-to-cytoplasmic ratios. This hallmark structural change 
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was visible with the microendoscope device. A pilot study was performed by imaging the 
epithelium of resected oral cancer specimens. A number of quantitative image features 
were calculated and used to construct an objective algorithm to classify regions within 
the resected tissue as neoplastic or non-neoplastic; these results were then compared to 
histopathology of the same site, and to subjective interpretations of the images by trained 
and untrained observers. To further explore the effectiveness of the device to detect oral 
lesions in a clinical setting, widefield images from a multispectral digital microscope 
were used to guide placement of the microendoscope, and quantitative features from both 
were combined in a synergistic classification algorithm. 
Specific Aim 3: 
We evaluated the performance of the imaging device to differentiate between 
Barrett's metaplasia and clinically significant disease, including Barrett's metaplasia with 
high grade dysplasia and esophageal adenocarcinoma. Glandular tissue is fundamentally 
different from the squamous lining of the oral cavity, oropharynx, and esophagus. High 
resolution imaging shows glandular structures which appear large, uniform and discrete 
in Barrett's metaplasia, with preservation of nuclear polarity along the base of the glands. 
High grade dysplasia or adenocarcinoma shows irregular, crowded glands with large 
nuclei, and loss of nuclear polarity. A pilot study was performed on biopsies and 
endoscopic mucosal resection specimens from patients undergoing endoscopic evaluation 
for esophageal neoplasia. We performed quantitative image analysis, as in Aim 2 above, 
and compared the results to subjective interpretations of the images by expert clinicians. 
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1.3 Chapter Summary 
The following dissertation is organized as follows: Chapter 2 presents relevant 
background information and cites current literature on the topic. Chapter 3 presents an 
initial study on the high-resolution microendoscopy system, including in vitro imaging 
using molecular targeted contrast agents, as well as ex vivo imaging on resected human 
oral tissue. Chapter 4 reports a quantitative analysis of an imaging study that 
demonstrates the ability of the microendoscope to distinguish between neoplastic and 
non-neoplastic tissue in human oral squamous epithelium. To demonstrate the ability of 
the microendoscope system to be integrated with other, wide-field imaging systems, 
Chapter 5 presents a quantitative analysis of a study using both systems to detect 
neoplastic lesions in human oral mucosa. Chapter 6 presents a qualitative assessment of 
the microendoscope's ability to image intestinal metaplasia. Chapter 7 is a quantitative 
analysis of the system's capability to distinguish between neoplastic and non-neoplastic 
tissue in a setting of intestinal metaplasia. Chapter 8 summarizes and discusses the 
important findings and implications of this dissertation. 
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Chapter 2: Background 
2.1 Oncogenesis and the Histology of Cancer 
To fully understand how the miniaturized imaging system will work, a discussion 
on the fundamental changes that occur during the progression to cancer is warranted. 
Generally speaking, cancer is the result of a continuum of changes that affect the ability 
of cells to control their division. Typically, damage to genes that either control cell 
division (oncogenes) or prevent cells from progressing to mitosis when inappropriate 
(tumor suppressor genes) lead to the possibility of development of cancer [3]. As an 
individual ages, such mutations become more likely to accumulate in these susceptible 
locations, accounting for the observation that cancers typically strike the older segment of 
the population. However, there are certain inherited mutations that can lead to cancers 
early in life; fortunately, such disorders are relatively rare. 
The hallmark of cancer is uncontrolled and unchecked cell replication. Due to 
abnormal amounts of DNA replication, nuclei of dysplastic cells can appear greatly 
enlarged, often comprising 90% of the cell's diameter. These nuclei often appear 
irregular and hyperchromatic due to of this abnormal DNA replication. Additionally, 
because of the high rate of mitosis, numerous dividing cells may be present in dysplastic 
tissues. As dysplastic cells divide more frequently, cells will appear crowded and push 
into locations where they do not normally reside. For example, in normal epithelial tissue, 
such as skin, there is a clear hierarchy of organization with a basal cell layer that divides 
to replenish cells above that are sloughed off. A dysplastic lesion in epithelial tissue can 
be graded based on what fraction of the epithelium has been replaced with the abnormal 
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cells. Higher grade lesions will involve progressively greater fractions of epithelium. If a 
lesion encompasses the entire epithelium but does not go beyond the basal layer of cells 
or past the basement membranes, this condition is termed carcinoma in situ. When 
abnormal cells can be seen to push beyond the basal cell layer and basal membrane and 
into the connective tissue beneath, malignant transformation is said to have taken place, 
and treatment for such a lesion will become significantly more aggressive. (Figure 2-1) 
Figure 2-1: H&E Slides showing normal (left) and dysplastic (right) epithelium in the 
cervix (University of Washington Department of Pathology) 
Analysis of the histology of removed tissues by a pathologist is the accepted 
standard of care for making a definitive diagnosis of cancer. The morphologic clues that 
can be used to aid the pathologist in making a diagnosis are described above. In recent 
years, however, additional tools have become available to improve the ability of the 
physician to make a diagnosis that are based on the molecular and metabolic features 
some types of cancers. Certain breast carcinomas have been shown to overexpress an 
extracellular tyrosine kinase receptor known as Her-2/neu. This receptor is involved in an 
estrogen signaling pathway and has been shown to be important in determining the 
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sensitivity of the cancer to a specific type of treatment [4]. Through a process known as 
immunohistochemisty (IHC), antibodies directed against this receptor can be introduced 
into the tissue, highlighting regions that express the abnormal receptor. Such molecular-
based strategies allows for more specific diagnoses and highly directed treatments based 
on the expression of such markers. In addition to antibodies, aptamers- short sequences of 
RNA that have been shown to bind proteins- have been used recently as targeting agents 
directed against certain receptors [5]. 
In addition to the visible changes that occur in tissues due to dysplasia and cancer, 
there are numerous molecular and metabolic changes that occur as well. Mitotically 
active cells require a large amount of resources to be able to maintain such a high rate of 
replication; as a result, their oxygen and nutrient demands are very high. Bloodflow to 
fast-growing tumors is often increased, and frequently associated with abnormal 
angiogenesis. This increased blood flow and altered metabolic activity within cells can be 
detected using various spectroscopic techniques. 
Despite the ability of these techniques to elucidate functional properties of tissues, 
there exists a need to evaluate tissues at higher resolution. Spectroscopic methods are 
unable to resolve tissues down to the cellular level and are therefore not able to 
differentiate between malignant neoplasias and certain other benign conditions- such as 
inflammation. Short of performing a surgical biopsy, several techniques exist that can 
examine tissue at high resolutions while being only minimally invasive. Needle biopsy is 
a common technique that can access virtually all parts of the body. A form of needle 
biopsy, fine needle aspiration (FNA) involves the insertion of a small hollow needle into 
a suspicious tissue, guided either by palpation, ultrasound, CT or other imaging 
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modalities. Suction is applied via negative pressure from a syringe at the opposite end of 
the needle to remove cells from the tissue undergoing the biopsy. These cells can be fixed 
immediately and stained to enable a fast diagnosis, and may also be saved for more 
specific studies to assess the specific nature of any tumor cells found, analogous to IHC 
as described above. While this procedure does not require general anesthesia and surgical 
complications are minimal, several passes may be required to attain enough cells for a 
proper diagnosis [6, 7]. Additionally, since cells removed via FNA are isolated from their 
surroundings, the architecture of the tissue cannot be visualized- an important aspect in 
making a pathologic diagnosis. 
While techniques that examine the structure of tissues removed from the body 
will remain the gold standard of pathologic diagnosis for the foreseeable future, rising 
healthcare costs and limited insurance availability has necessitated the development of 
less invasive, rapid, and simple tests that still maintain high levels of sensitivity and 
specificity. The ability to clearly distinguish between normal tissue and abnormal tissue 
that has either become dysplastic and is at risk for malignant transformation or has 
already begun to metastasize remains the focus of these newer techniques. 
2.2 Contrast Agents 
Distinguishing dysplastic tissues from normal tissues through the use of an 
imaging modality is dependent upon a difference in contrast between the two tissue types. 
Fortunately, there are native contrast variations that can be visualized with minimal 
additional processing. As previously mentioned, increased DNA synthesis in the nuclei of 
dysplastic cells renders their nuclei large, hyperchromatic, and highly reflective [3]. This 
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increased reflectivity of dysplastic nuclei has been exploited in reflectance-based imaging 
techniques to highlight suspicious areas in tissues. 
Cervical cancer screening has taken advantage of this concept for many years 
through the use of colposcopy. This imaging technique uses relatively low power 
microscopy to visualize the epithelium of the cervix. While a dysplastic lesion may not 
always be readily apparent, a weak solution of acetic acid is commonly applied, which 
enhances the contrast between normal and abnormal epithelium, a process known as 
acetowhitening. The mechanism of this reversible process is not well understood, but 
likely involves the clumping of chromatin, which in turn further enhances the reflectivity 
of nuclei by increasing the refractive index mismatch between the nuclei and cytoplasm. 
This leads to an increase in backscattered light from the tissue [8]. This effect causes 
dysplastic tissue, with its greater chromatin content, to reflect more light than its 
surroundings, improving the chances that a clinician will be able to observe the lesion 
and take the appropriate steps to secure an accurate diagnosis. 
In addition to acetic acid, other cancer-specific contrast agents have undergone 
clinical study. One such compound is toluidine blue, a metachromatic dye that can easily 
be applied to epithelial tissues [9-19]. It has been theorized that this dye binds to 
negatively-charged chromatin in the nuclei of cells, thereby preferentially staining the 
nuclei of cells that have become dysplastic. The result is not dissimilar from what is seen 
with the acetowhitening effect: dysplastic or malignant lesions stand out from the 
background of normal epithelium, alerting a clinician that further study is required. A 
visual inspection of the oral cavity using Toluidine blue takes only a few minutes and 
utilizes reagents that are readily available and inexpensive. Other non-targeted dyes, such 
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as cresyl violet and rose bengal, has also shown promise as inexpensive markers that may 
be selective for dysplastic and cancerous tissues. Both of these have the added benefit of 
being fluorescent, simplifying the design of imaging systems intended to work with these 
dyes [20-24]. 
While these techniques are inexpensive and allow for rapid screening, their 
specificities are not sufficient enough to entirely replace biopsies. Toluidine blue, for 
example, has been shown to have a high false-positive rate as well [12-15]. These 
methodologies still need to be able to demonstrate a high degree of sensitivity and 
specificity. With the advent of molecular targeting strategies, it is possible to achieve 
acceptable levels of specificities in a number of diagnostic strategies. 
Immunohistochemistry (IHC), as discussed previously, has been shown to target 
with a high degree of specificity abnormal cells that express certain proteins. These 
proteins can be isolated and antibodies produced that are specific only to these molecules. 
Examples include cell membrane localized receptors, secretory products like matrix 
metalloproteinases, abnormal cell signaling proteins, and a host of other classes of 
intracellular and extracellular proteins [25]. With the use of antibodies, diagnostic tests 
can be tailor-made to certain types of cancers that express these specific molecules. For 
diagnostic tests that rely on imaging modalities, the ability to link these highly specific 
antibodies to markers that enhance the contrast of dysplastic regions is desirable. These 
markers can be either highly reflective or absorbing for reflectance-based imaging 
strategies or fluorescent for fluorescent imaging modalities. Gold nanoparticles have 
shown much promise in reflectance imaging, as they are easily linked to antibodies or 
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other targeting molecules and exhibit desirable reflectance properties under the 
appropriate conditions [26]. 
Fluorescent imaging techniques hold much promise in maximally increasing the 
contrast between normal and abnormal tissues [27-30]. Fluorescent emission light is 
easily filtered from background excitation light, resulting in a high signal-to-background 
ratio when imaging in the proper conditions. Proflavine is an acridine-derived dye that 
has been postulated to bind to DNA in a reversible and non-covalent manner by 
intercalating between base pairs. Proflavine and other acridine-derived compounds 
exhibit anti-bacterial properties as a result of this DNA-binding mechanism, which also 
makes it well-suited as a nuclear fluorescent contrast agent. This nuclear staining pattern 
is very useful in cancer imaging applications since it allows for visualization of the 
overall cellular architecture, nuclear-to-cytoplasmic ratios, and other important metrics 
with minimal sample preparation or incubation time. Acriflavine hydrochloride is a 
compound containing both proflavine and euflavine, and has been used in a number of GI 
imaging studies [31, 32]. 
Recently, much work has been accomplished in the field of semiconductor 
nanocrystals, or quantum dots. These are fluorescent crystals that have several highly 
advantageous properties for biological imaging: a broad excitation profile, a narrow and 
tunable emission profile, limited photobleaching, and they are able to be passivated and 
functionalized to accept targeting antibodies on their surfaces. Quantum dots also exhibit 
a high quantum efficiency and a large Stokes shift, meaning that relatively little 
excitation light would be required to generate a signal, and this excitation light is easily 
filtered from the emitted light. Quantum dots and quantum dot-antibody conjugates are of 
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an ideal size for labeling tissues - usually between 2 to 10 nm [33]. These small sizes 
allow for the particles to pass through tissues and contact cell membranes, and can even 
be used to label intracellular targets [34]. Quantum dots have been used extensively in 
recent years to labels cultures of tumor cells in vitro as well in small animal models for 
cancer imaging related studies [35-39]. 
Targeting of quantum dot fluorescent markers with the aid of antibodies, 
aptamers, or other means would allow clinicians to monitor the expression levels of 
extracellular receptors like Her-2 and EGFR (epidermal growth factor receptor). The 
newly developed drugs Trastuzumab and Cetuximab block Her-2 and EGFR receptors 
and have been shown to be beneficial in breast cancers that express those receptors [4, 
38,40]. By directly visualizing these receptors over the course of treatment, it may be 
possible to track the progression and response of cancers to treatment. 
2.3 Imaging Modalities 
With recent advances in computing and optical technologies, it has become 
feasible to develop systems specifically designed to detect neoplasias by imaging tissues 
in a minimally invasive fashion. Such techniques do not require the removal of tissue 
from the body; rather, a small optical device is held in direct contact with very close to 
the tissues to be imaged. Such a procedure can be performed without any of the 
associated costs or discomforts to the patient a traditional biopsy would present. 
Standard microscopy does not work well on in vivo tissues because of the inherent 
turbidity present. Since tissue is highly light scattering, light from outside the focal plane 
of interest will be present in the image plane of any microscope device. With standard 
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histopathology, tissue is sliced to form an extremely thin film, whereby essentially all of 
the material to be observed can be effectively focused. For imaging in live tissues, a 
technique known as optical sectioning has been shown to provide detailed structural data 
without needing to physically section tissues. 
Confocal microscopy has been used for a number of years for in vitro 
applications, but has recently been shown to be useful for the imaging of ex vivo biopsies 
and in vivo tissues[41-43]. A confocal microscope works by focusing the illumination on 
a small point within the plane of interest. The returning light, which may be either 
reflected light or fluorescent light, is then focused through a small pinhole at the 
conjugate image plane. A photodetector placed just behind this pinhole serves to collect 
this incident light. Light that returns from outside the focal plane of interest is then 
rejected by the outside of the pinhole, thereby reducing the out-of-focus scattered light 
that may otherwise be collected. To create a full image, the illumination is scanned across 
the entire desired X-Y plane of the frame. The final image lacks the color of a 
histopathology slide, and is dependent upon refractive-index mismatching (in the case of 
reflectance imaging) to elucidate nuclei from cytoplasm or other structures. 
Despite the advantages of confocal imaging, there are significant drawbacks 
inherent in its design that limits the potential applications. Since illumination must be 
directed into the tissues and recollected, the penetration depth of confocal microscopy is 
limited by how deeply the light can pass into tissues. While longer wavelengths of light 
tend to scatter less and penetrate more deeply into tissues, even near-infrared (NIR) 
systems can only image to a depth of about 1000 microns effectively[41]. Additionally, 
while miniaturization of confocal systems in recent years has created progressively 
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smaller instrumentation, including a confocal endoscope, the optical and mechanical 
elements of these systems have generally limited the usefulness of this technique to easily 
accessible regions of the body [32,44-50]. 
One technique to overcome these limitations of high-resolution confocal imaging 
is to deliver the light into the tissue at the site where imaging is to take place. This clearly 
requires significant miniaturization of optics to accomplish. Through the use of optical 
fibers, which have been highly developed through the telecommunications and other 
industries, we are now able to build small, flexible optical devices capable of such tasks. 
Optical fibers consist of a dielectric core material and a dielectric cladding, which has a 
slightly lower refractive index. Light then propagates through the fiber through total 
internal reflection, acting like a light guide[51-55]. For short lengths of these fibers and at 
visible wavelengths, the amount of signal that is lost through these fibers is minimal[56, 
57]. 
Optical fibers can be bundled together in an array of parallel fibers. This fiber 
bundle is referred to as an image guide. These image guide bundles are able to transfer a 
pixellated image from one face of the bundle to the other since each individual pixel 
element (fiber) is organized and parallel to each other[58]. This type of fiber bundle can 
be used for biological microscopy applications, since any tissue that is placed upon the 
distal surface of the bundle will yield an image on the proximal side that can be 
magnified through the use of more conventional optics. Tissues that are in immediate 
contact with the fibers at the end of the bundle will be "imaged" onto the other side, since 
the focal points for each fiber essentially occurs at the fibers' ends[59, 60]. This image 
can then be focused onto a CCD or other detector for post-processing. The resulting 
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image consists of the same number of usable pixels as the bundle has individual fibers; 
therefore, the physical properties of the image guide bundle itself is a major determinant 
of the performance of the overall system. Clearly, smaller individual fibers in the bundle 
will yield a higher-resolution image, while a larger diameter image guide will yield a 
larger field of view. The optics used to magnify the proximal bundle face determines the 
overall magnification of the system, but this magnification will be limited by the size of 
the individual fibers in the bundle. 
Fiber bundle image guides overcome the limitations of standard confocal imaging 
by delivering the light and the optics directly to the tissues that are to be imaged. 
Illumination of the desired tissue can be achieved by passing excitation light directly 
through the same image guide that receives the image. Fluorescence excitation light can 
easily be filtered out before the light reaches the detector with a long pass filter. Reflected 
light imaging requires the removal of the specular reflection from both the proximal and 
distal ends of the fiber bundle. Using polarized light at the source and an appropriate 
beam splitter, it is possible to reduce the reflection from the proximal surface of the 
image guide. Polishing the distal end of the fiber bundle at such an angle that the 
reflection will be outside the numerical aperture of the fibers reduces the reflection from 
the distal tip of the fiber bundle. This reduces the overall undesirable background present 
in the final image. 
Fiber optic image guides can be manufactured to extremely small diameters and 
offer a means to potentially image deep tissues within the body not otherwise easily 
accessible. Image guides less than approximately half a millimeter (500 microns) are 
easily passed through the lumen of relatively small 16 to 18 gauge needles, and could 
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therefore be placed directly into contact with masses or lesions that cannot be 
interrogated with standard confocal microscopic techniques. Additionally, since the 
illumination light will pass through the same image guide bundle, there is no concern 
about the limited transport depth of light in tissue. 
Such miniaturized fiber optic bundle microscope systems are ideally suited for 
oncologic imaging applications. Fine needle aspiration (FNA) is widely performed as a 
simple outpatient procedure today in order to remove cells from suspicious masses[6, 7]. 
Two of the most common forms of cancer, breast and prostate, occur at sites that are 
relatively accessible to a needle biopsy probe, and therefore accessible to an image guide 
microscope system. An image guide could easily provide on-the-spot histologic 
information about such a mass with no more pain or discomfort to the patient than an 
FNA. However, since cells can be viewed in the context of their surroundings- unlike 
FNA, which removes individual cells at random, image guide microscopy may provide a 
pathologist with additional useful information. Furthermore, there would be no need to 
process and fix the cellular material, potentially reducing per-patient operating costs. 
2.4 Development and Characterization of an Image Guide Microscope 
This section will illustrate the design and performance of the first generation fiber 
bundle image guide-based microscope system. In order to design such a system, it is 
necessary to review the desired applications of the device as well as the desired 
performance characteristics. Since this image guide system is to be used to image tissues 
that are not necessarily superficial, it is important to determine a means of delivering the 
distal end of the image guide to the tissue in question. It was determined that a single 
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hollow 16 to 18 gauge needle could be inserted into the tissues and used as a conduit 
through which a small fiber bundle image guide could be passed. The lumens of these 
hollow needles are approximately 500 microns to 1 millimeter in size, placing an upper 
limit on the outer diameter of the fiber bundle in that range. Also, in order to achieve 
sufficiently useful resolution, it is important to be able to resolve individual cells; thus, 
this places a minimum lateral resolution limit of about 5 to 10 microns for the microscope 
system. Since this system is intended to be a low cost / high volume screening tool, 
selection of the illumination source is critical. Light emitting diodes (LEDs) are currently 
being produced that have desirable spectral characteristics (small bandwidth, down to 20 
nm FWHM) and illumination intensity (hundreds of milliwatts) and cost only dollars per 
unit. Their ability to function for thousands of hours and their inexpensive replacement 
costs makes LED's ideally suited for this application. Finally, a CCD camera with 
extremely high sensitivity would be used to detect the rather weak fluorescent emission 
light returning from the fiber bundle. It was decided that the ability to integrate frames 
was a characteristic necessary to achieve the needed sensitivity in this application, 
although long exposure times would also be acceptable. However, CCD devices that can 
attain long exposure times require very low-noise circuitry, driving up the costs. 
The remainder of the optical train is very similar to that of a standard light 
microscope mounted on its side. Collimated light exiting the objective lens must be 
focused onto the plane of the CCD camera. This is accomplished through the use of a 
"tube" lens, of which the focal length is very important. (Figure 2-2) The focal length of 
this tube lens is directly proportional to the magnification of the optical setup, which is 
given by the simple relation: M = ftubeiens / fobjective • The focal length of the objective 
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lens is given by the manufacturer to be 18 millimeters, therefore an appropriate tube lens 
focal length was selected to be 250 millimeters to give an overall magnification of about 
14X, sufficient to produce an acceptable image scale for the CCD detector. This 
theoretical value was confirmed experimentally by measuring the image size of US Air 
Force (USAF) resolution target lines that were projected onto the CCD detector. Since 
the size of each pixel in the CCD array is known, counting pixels allowed the projected 
image size to be evaluated, and confirmed that the system magnification was 
approximately 14X. 
A novel technique used in this device is the implementation of an LED as its 
primary light source. Excitation of quantum dot and other fluorophores was stated as a 
LED 
u
 Source X . 
Figure 2-2: Schematic of fiber bundle microscope system (a) and illustration of relative 
size of fiber optic image guide (b). 
major design goal. These quantum dots have desirable absorption cross sections such that 
illumination over a broad wavelength range in the blue region of the spectrum would be 
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sufficient, eliminating the need for a laser or arc lamp, which are the standard methods 
for excitation of many fluorescent molecules. 
The image guide microscope can be used for both fluorescence and reflectance 
image with minor changes in the optical setup. Fluorescence imaging requires a dichroic 
mirror in the objective lens pathway and both an exciation and emission edge-pass filter 
placed in front of the LED and the CCD respectively. This setup effectively illuminates 
the proximal face of the image guide and eliminates any remaining excitation light before 
entering the CCD. For reflectance imaging, the edge-pass filters are removed and the 
dichroic mirror is replaced with a polarizing beam splitter (PBS) cube. This PBS cube 
splits the incoming unpolarized light to s- and p-polarizations and sends only one type of 
polarization to the proximal face of the image guide. Specular reflection from this surface 
will remain polarized in the direction that is unfavorable to be passed through to the 
camera. In addition, the distal end of the fiber bundle is polished at a 10-degree angle, 
which reduces the amount of reflected light from this surface by directing it outside the 
acceptance cone of the individual fibers in the image guide. This acceptance cone is 
defined by the numerical aperture (NA) of the fibers given in the image guide 
specifications (NA ~ 0.35). 
An alternative means for reflectance imaging has been explored which separates 
the illumination channel entirely from the imaging arm. In this setup, the LED is used to 
illuminate two single, 200 micron diameter optical fibers, which are then localized in 
flanking positions around the image guide. Light then enters the tissue from the side of 
the image guide and a portion will be backscattered into the acceptance cone of these 
imaging fibers. Cells on the surface of an epithelium that have been labeled with 
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absorbing dye or other materials will then appear to be backlit by this backscattered light, 
forming an image of dark cells in a light background. This application effectively 
eliminates any unwanted specular reflection from the system. 
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Chapter 3: Subcellular-resolution molecular imaging within living 
tissue by fiber microendoscopy1 
3.1 Abstract 
Conventional histopathology involves sampling, sectioning and staining of tissue 
specimens prior to microscopic evaluation, and provides diagnostic information at a 
single location and point in time. In vivo microscopy and molecular-targeted optical 
labeling are two rapidly developing fields, which together have the potential to provide 
anatomical and functional indications of disease by staining and imaging tissue in situ. 
To address the need for high-resolution imaging instrumentation, we have developed a 
compact, robust, and inexpensive fiber-optic microendoscopy system based around wide-
field LED illumination, a flexible 1 mm diameter fiber-optic bundle, and a color CCD 
camera. We demonstrate the sub-cellular resolution imaging capabilities of the system 
through a series of experiments, beginning with simultaneous imaging of three different 
cancer cell lines in culture, each targeted with a distinct fluorescent label. We used the 
narrow diameter probe to access subcutaneous tumors in an in vivo murine model, 
allowing direct comparison of microendoscopy images with macroscopic images and 
histopathology. A surgically resected tissue specimen from the human oral cavity was 
imaged across the clinical margin, demonstrating qualitative and quantitative distinction 
between normal and cancerous tissue based on sub-cellular image features. Finally, the 
fiber-optic microendoscope was used on topically-stained normal human oral mucosa 
This chapter has been published previously in Muldoon T, Pierce MC, Nida D, Williams MD, Gillenwater 
A, Richards-Kortum R. Subcellular resolution molecular imaging within living tissue by fiber 
microendoscopy. Optics Express 2007;15: 16413-23. 
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in vivo, resolving epithelial cell nuclei and membranes in real-time fluorescence images. 
Our results demonstrate that this imaging system can potentially complement 
conventional diagnostic techniques, and support efforts to translate emerging molecular-
diagnostic and therapeutic agents into clinical use. 
3.2 Introduction 
In many clinical situations, visualization of cellular morphology and architecture 
is mandatory, requiring an excisional biopsy or fine needle aspiration to obtain tissue or 
cells for histopathology. Such procedures are invasive, sometimes dangerous, expensive, 
and the results are not immediately available. This clinical need has motivated the 
development of techniques for imaging tissue in situ with cellular resolution, aimed at 
complementing the pathologist's expertise though biopsy guidance and monitoring of 
disease progression and treatment. By analogy with chemical staining in histopathology, 
contrast between tissue components can be obtained in situ through topical or intravenous 
delivery of fluorescent agents. While non-specific dyes have been widely used to 
generate optical signals for in vivo imaging, an expanding array of targeted fluorescent 
probes are emerging that can provide indicators of disease at the cellular and molecular 
levels [35, 61-63]. This ability to detect and monitor the presence and activity of disease 
biomarkers is expected to have considerable impact in fundamental biomedical research, 
and ultimately on the clinical management and care of patients [64, 65]. As research in 
the molecular imaging field proceeds through studies in cell culture, animal models, and 
pre-clinical trials, robust, versatile, high-resolution optical imaging instrumentation is 
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essential at each stage, and ultimately to accompany molecular imaging into the clinical 
setting. 
Flexible, narrow-diameter optical fibers are well-suited for performing 
microscopic imaging at sites within the human body [29], and several researchers initially 
demonstrated the feasibility of using a length of single-mode fiber as a conduit through 
which confocal microscopy could be performed [66-68]. Such configurations using only 
a single optical fiber require a means of scanning the emerging optical beam across the 
specimen in order to build up an image, which to date, still represents the overall limiting 
factor in system miniaturization. Scanning mechanisms based on miniature mirrors [69-
71], piezoelectric actuators [72], spectral encoding [73] and electromagnetic vibration 
[74] have all been demonstrated, with the latter technique used to construct a scan head 
integrated into a standard 1.2 cm diameter clinical endoscope, providing access to hollow 
internal cavities including the gastrointestinal tract and colon [75, 76]. 
A related approach that eliminates the requirement for a scanning mechanism at 
the distal (sample) end of a fiber, involves the use of a coherent fiber bundle, comprising 
thousands of individual optical fibers within a single element of sub-millimeter diameter 
[59, 77]. The use of a coherent bundle enables the scanning mechanism to be located 
outside the body at the proximal end of the fiber, with the scan pattern faithfully 
reproduced at the distal end due to the ordered arrangement of individual fibers. The fiber 
bundle approach has been used for both reflectance [77, 78] and fluorescence [28, 59, 79, 
80] confocal imaging, in both two-dimensional point scanning and one-dimensional line 
scanning variations [81, 82]. The primary drawback of the fiber bundle approach is the 
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appearance of the bundle structure superimposed on each image, although this artifact 
can be reduced by image processing methods [28, 83]. 
In this article, we present a high-resolution fiber-optic fluorescence imaging 
system for visualizing sub-cellular detail in living tissue. Based on wide-field imaging 
through a coherent fiber bundle, all scanning requirements are eliminated, and through 
the use of LED illumination and CCD imaging, we have developed an inexpensive 
system that is both simple to implement and robust in use. We demonstrate the 
capabilities of the system through a series of experimental studies in biological systems, 
leading to in vivo human imaging. First, we performed multiplexed imaging of a cell-
culture model containing three cancer cell lines, discriminating between cell type based 
on the different fluorescent markers targeted to each. We then imaged a murine tumor 
model in vivo, allowing comparison with features evident in standard macroscopic 
imaging and histopathology sections. Next, a surgically-resected cancerous human tissue 
specimen was imaged, enabling real-time visualization and quantification of cellular 
features across the margin between diseased and healthy tissue. Finally, the system was 
used in a healthy human subject in vivo, demonstrating its ability to acquire stable images 
with sub-cellular resolution, non-invasively and in real-time. Our results indicate that this 
type of simple and inexpensive fiber-optic imaging platform can extract qualitative and 
quantitative information with high-resolution from fluorescently labeled cells and tissues. 
These capabilities can potentially be used in conjunction with existing and emerging 
molecular-targeted fluorescent probes, in areas ranging from cell culture studies to 
clinical imaging in human subjects. 
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3.3 Materials and methods 
3.3.1 Fiber-optic microendoscopy system 
The primary components of the imaging system are a light source, a fiber-optic 
bundle, a microscope objective lens, and a CCD camera (Figure 3-1). The LED light 
source (Luxeon) produces an optical spectrum centered at 455 nm (20 nm FWHM), and 
costs less than $5 per unit. A collimator directs light from the LED to the back aperture of 
a lOx / 0.25 NA infinity-corrected objective lens (Olympus), via a 475 nm cut-off 
dichroic mirror (Chroma Technology Corp.). Excitation light illuminating the proximal 
end of a flexible fiber-optic bundle (Sumitomo, IGN-08/30) is transferred coherently to 
the distal end. The distal tip of the bundle (Figure 3-1) is placed in direct contact with the 
sample, delivering 1 mW excitation power. Fluorescence emission from the sample is 
collected by the bundle, transmitted through the dichroic mirror and imaged onto a CCD 
camera by a tube lens with magnification factor, M. This factor is chosen to balance the 
conflicting requirements of sampling individual fibers with a sufficient number of pixels 
at the CCD, whilst confining the magnified image of the bundle to the area of the CCD 
array. Since the physical size of the bundle determines the field-of-view, the maximum 
achievable FOV is related to the CCD and bundle properties according to Eq. (1), where 
WCCD is the CCD size, wp the pixel size, fa the fiber core diameter, and n the desired 
number of samples (pixels) per fiber: 
Two different CCD cameras were evaluated in this work; the results shown in 
Figures 3-4 and 3-5(a) were acquired by a scientific-grade color CCD camera (Retiga 
27 
EXi, Qlmaging, Inc.), using IEEE 1394 (Firewire) output to directly send continuous 
image data to a computer. The results shown in Figures 3-2, 3-3, and 3-5(b) were 
acquired by a standard analog CCD camera (CV-S3200N, JAI, Inc.), with image 
acquisition card (National Instruments). Using Eq. (1), the maximum field-of-view at the 
Nyquist limit (n = 2) is 1416 pm and 539 um for the Retiga and JAI cameras, 
respectively. Both cameras use a Bayer mask for color imaging and were digitized at 8-
bit resolution. Relevant experimental parameters are summarized in Table 3-1. 
Array size 
Pixel size 
Number of pixels 
Relay magnification, M 
Pixels per fiber at CCD 
Dynamic range 
Least significant bit at 8-bit 
A/D* 
JAI 
6.6 x4.8 mm 
8.4 x 9.8 um 
768 x 494 
7x 
1.6 
50 dB 
1.2aread 
Retiga 
10.2 x 8.3 mm 
6.45 x 6.45 um 
1392x1040 
lOx 
3.4 
67 dB 
8.8crreaci 
Read noise, aread 
Table 3-1: Experimental parameters of each CCD camera 
The total cost of the fiber microendoscopy system was $2500 with the standard 
CCD camera, and $11,000 with the scientific-grade unit. 
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Figure 3-1: Fiber-optic microendoscopy system, (a) Schematic diagram, (b) Photograph 
of fiber-optic bundles on a US penny. Bundles 1 and 2 have outer diameters of 1.0 mm 
and 0.5 mm respectively. 
3.3.2 3-D cell culture and labeling 
Two tyrosine-kinase receptors shown to be overexpressed in epithelial cancers, 
Her-2 and EGFR, were selected as the antibody targets. Labeling of these extracellular 
receptors was accomplished using a biotin-antibody conjugate (Neomarkers) and a 
commercially-available quantum dot-strepatavidin conjugate (Invitrogen).Multiplexed 
labeling was performed using the two extracellular targets (Her-2 and EGFR) and a green 
nucleic-acid specific cell dye (SYTO 45, Invitrogen). EGFR was targeted with a red Qdot 
655 / streptavidin conjugate, while Her-2 was labeled with a yellow Qdot 585 / 
streptavidin conjugate. Following labeling, equal numbers of each of these cell types 
were suspended in collagen. All three fluorophores have spectrally distinct emission 
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spectra but similar absorption spectra, permitting all to be excited with the LED's 
emission centered at 455 nm. Images of the tri-color fluorescent collagen construct were 
taking using a 500 nm long-pass filter (Thorlabs) for the green nuclear stain, a 20 nm 
FWHM bandpass filter centered at 585 nm for the Her-2 fiuorophore, and a 20 nm 
FWHM bandpass filter centered at 655 nm for the EGFR fiuorophore (Chroma 
Technology Corp.). These individual frames were then uniformly processed by enhancing 
contrast and applying a false color (ImageJ). Additionally, a fully-multiplexed imaging 
mode is achieved by using the camera's color imaging capability. A single 500 nm 
long-pass emission filter was used, with the CCD camera's Bayer mask used to 
distinguish between each fluorescent cell species. 
3.3.3 Murine tumor model and macroscopic imaging 
1483 cells (provided by Dr. P. G. Sacks, New York University College of 
Dentistry, New York, NY), derived from a human oropharyngeal squamous carcinoma, 
were injected into the subcutaneous tissue of athymic nude mice. The tumors were grown 
for approximately 2 to 3 weeks, until they were greater than 5 mm in size, in accordance 
with a protocol approved by the Institutional Animal Care and Use Committee at Rice 
University. To visualize the tumor at low resolution within the context of the whole 
animal, macroscopic imaging was performed using a small animal imaging system (CRI 
Maestro). To enhance visualization of the tumor in both whole animal imaging and 
during fiber microendoscopy, the tumor was directly injected with 0.05% acriflavine 
hydrochloride in PBS. Acriflavine is a non-DNA binding fluorescent molecule that 
associates with the negatively charged nucleus allowing for optimal visualization of 
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overall tissue architecture. Following a 20 minute incubation period, the skin of the 
animal was pierced with a 16-gauge needle, and the 1 mm diameter fiber-optic bundle 
inserted into the tumor. Images and video were acquired while the animal remained under 
anesthesia. On completion of the microendoscopy imaging, the tumor was removed and 
subject to routine histologic processing with H&E staining. 
3.3.4 Surgical specimen acquisition and imaging 
Through a study protocol approved by both the Rice University and University of 
Texas M.D. Anderson Institutional Review Boards and following informed consent by 
the patient, a surgical specimen containing an oral squamous carcinoma located in the 
buccal mucosa and retromolar trigone was obtained immediately after surgical resection. 
Acriflavine solution (0.05% in saline) was applied to the mucosa of the specimen, and 
imaging with the microendoscope followed immediately thereafter. The specimen was 
subsequently sent for routine histologic processing, which generated H&E stained 
sections from locations closely corresponding to those imaged with the fiber 
microendoscope. 
3.4 Results 
3.4.1 System characterization 
The spatial resolution of the imaging system is governed by the size and spacing 
of individual fibers in the coherent bundle. In the system presented here, the fiber core 
size is 2.2 urn, with a center-to-center spacing of < 4 urn. An image of a standard 
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resolution target demonstrates the system's ability to resolve lines that are 4.4 urn in 
width (Figure 3-2(a)). The field-of-view simply corresponds to the active area of the fiber 
bundle, which is 350 urn in diameter with the fiber bundle used here and 750 um in the 
remaining figures in the text. 
Figure 3-2: System resolution and multiplexed cell culture imaging, (a) Image of a 
standard US Air Force resolution target, demonstrating resolution of the 4.4 micron-wide 
bars in group 6, element 6 (circled), (b) False-color composite image of a 3-D collagen 
construct containing 1483 oral squamous cell carcinoma cells (red), SK-BR-3 breast 
cancer cells (green), and SiHa cervical cancer cells (blue), with each cell type stained 
with a spectrally-distinct fluorophore. (c) Single frame image of the same tissue 
construct acquired in real-time with a single long-pass emission filter. 1483 cells appear 
red, SK-BR-3 cells yellow, and SiHa cells appear light green. All scale bars represent 50 
microns. 
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3.4.2 Multiplexed imaging 
Histopathology typically involves the addition of different chemical stains to 
individual tissue sections, to generate contrast between tissue components or assess 
molecular activity under light microscopy. A fundamental goal of in vivo molecular 
imaging is to achieve analogous staining in situ, through the use of molecular-targeted 
fluorophores. The fiber microendoscope can image and distinguish between cells stained 
with spectrally-distinct fluorescent labels within a single sample. We demonstrated this 
ability in an in vitro system, consisting of three different cancer cell lines, each labeled 
with a different fluorophore and suspended in a three-dimensional collagen construct. All 
three fluorophores were excited by the same LED light source, and individual images 
were acquired sequentially with three separate emission filters. Following background 
subtraction, contrast enhancement and false coloring, a composite image was formed, 
with 1483 cells appearing red, SK-BR-3 cells green, and SiHa cells blue (Figure 3-2(b)). 
To distinguish different fluorescent labels simultaneously, the CCD camera's Bayer mask 
can be used, eliminating the need to exchange separate emission filters and providing 
real-time multiplexed imaging. This technique is subject to cross-talk due to spectral 
overlap between the three Bayer mask elements, but the effect can be minimized by use 
of fluorophores that are as spectrally distinct as possible. The peak wavelengths of the 
three fluorophores used in this experiment were isolated by at least 50 nm. A single 
image of the same triple-labeled cell construct was taken with a 500 nm long-pass 
emission filter (Figure 3-2(c)). The three cancer cell types can again be differentiated, 
this time based on correspondence between individual fluorescent emission spectra and 
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the spectral transmission curves for each channel (red, green, and blue) of the Bayer 
mask. 
3.4.3 In vivo tumor imaging 
Clinical diagnosis of suspected tumors requires collection of tissue samples for 
histopathology, an invasive process which must be iteratively repeated when multiple 
suspicious lesions are present or margin determination is required. Each sample provides 
information at only one location and at one point in time, leading to sampling error and 
the need for multiple biopsies at initial and follow-up clinical visits. The flexible, narrow-
diameter fiber microendoscope can repeatedly access internal and sub-surface tissue sites 
in a minimally-invasive fashion. We imaged established subcutaneous tumor xenografts 
in athymic nude mice after fluorescence labeling, first with a macroscopic imaging 
system (CRI Maestro), and then with the fiber-optic microendoscope (Figure 3-3). Prior 
to imaging, the tumor was directly injected with acriflavine hydrochloride, a nuclear-
associating green fluorescent stain originally used as a topical antiseptic [84], and since 
as a source of contrast in confocal microscopy [75, 76]. The tumor mass was clearly 
visible with the macroscopic imager (Figure 3-3(b)). The fiber microendoscope was then 
introduced into the tumor through the lumen of a 16-gauge needle. As the 
microendoscope was advanced through the tissue, cellular architecture and morphology 
could be visualized in real-time. Nuclei appear as discrete green dots, with continuous 
green fluorescent regions likely arising from acriflavine uptake in desmoplastic tissue 
containing fibroblasts within the tumor mass (Figure 3-3(c)). For direct comparison, an 
H&E stained histological section (Figure 3-3(d)) is shown alongside a fiber 
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microendoscope image at the same scale, indicating invasive moderately-differentiated 
squamous carcinoma cells (dark blue-stained) and reactive desmoplastic (fibrous) tissue 
from the host response (appearing pink-stained). 
Figure 3-3: Murine tumor model imaging, (a) Photograph of an athymic nude mouse 
showing the fiber microendoscope and subcutaneous tumor. (b) Macroscopic 
fluorescence image (CRI Maestro) acquired following direct injection of fluorescent 
contrast agent at the tumor site, (c) Image acquired by the fiber microendoscope in the 
living mouse, as the fiber is advanced through the tumor within the lumen of a 16-gauge 
needle. Tumor cell nuclei appear as bright green dots, with connective tissue within the 
tumor mass, (d) Corresponding histology section following tumor excision. Scale bars 
represent 100 microns. 
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3.4.4 Ex vivo human specimen imaging 
Histopathologic processing and inspection by an experienced pathologist remains 
the gold-standard for diagnosis and classification of disease, but there are opportunities 
for optical imaging to complement established practice in areas such as biopsy guidance 
and surgical margin detection. In order to demonstrate the ability of the microendoscope 
system to discriminate and quantify changes associated with cancer, the device was used 
to image a surgical specimen containing an oral squamous carcinoma located in the 
buccal mucosa and retromolar trigone. With the fiber microendoscope tip placed in 
contact with the specimen at a clinically-normal region, bright, sparsely distributed nuclei 
are visible (Figure 3-4(a)). In contrast, as the fiber probe was moved to the region 
clinically-determined to contain the tumor (Figure 3-4(b)), nuclei qualitatively exhibited 
the characteristic increase in density and disorganization associated with cancer [85]. 
Corresponding histopathology sections are also presented and were reviewed by a board-
certified pathologist (MDW). The histology in Figure 3-4(a) demonstrates normal 
epithelium with some inflammation, while Figure 3-4(b) indicates the presence of 
squamous carcinoma cells extending to the tissue surface. The sub-cellular features which 
were qualitatively visualized in real-time using the fiber microendoscope were further 
evaluated by quantitative determination of nuclear-to-cytoplasmic (N/C) ratio, a 
recognized indicator of cancer and pre-cancer development. The images shown in Figure 
3-4 were visually inspected, with nuclei outlined manually using image processing 
software. Pixels in each nuclear region were then assigned a value of 1, with the 
remainder of the image (corresponding to cytoplasmic area) assigned a value of zero, 
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producing binary images for each sample. Nuclear-to-cytoplasmic ratios were then 
calculated from the numbers of pixels in each group. Automated image processing 
techniques may allow for a more rapid and less labor-intensive means of isolating cell 
nuclei, but for this example, visual identification of nuclei was used to ensure 
identification of nuclei that were clustered, or in relatively low-contrast regions. The use 
of the scientific-grade camera, with its improved image contrast, greatly facilitated this 
process. Images acquired in the tumor region demonstrated a marked increase in N/C 
ratio compared to the clinically normal region (Figure 3-4(c)). The dashed line represents 
an N/C ratio of 0.08, a threshold value determined by Collier et al. for discrimination 
between normal and cervical intraepithelial neoplasia (CIN) 2/3 in cervical biopsy 
specimens, through the use of reflectance confocal techniques [85]. 
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Figure 3-4: Surgical specimen imaging, (a) Normal epithelium. Left; photograph of 
fiber probe in contact with excised tumor tissue. Yellow border represents the clinically-
abnormal region identified by the surgeon (AG). Center; microendoscopy image of 
tissue with probe at location indicated in photograph. Right; corresponding transverse 
histopathology section from the imaged region, (b) Tumor region. Microendoscopy 
image (center) and histology (right) demonstrate squamous carcinoma throughout the 
entire epithelium. Scale bars represent 100 urn. (c) Graph of calculated nuclear to 
cytoplasmic ratio for microendoscopy images in (a,b). The dashed line represents an N/C 
ratio of 0.08. 
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3.4.5 In vivo human subject imaging 
A growing number of targeted optical contrast agents are gaining approval for 
human use, raising the prospect of combining molecular-specific fluorescent staining 
with fiber-optic imaging to perform an optical biopsy in living tissue. We used the fiber 
microendoscope system to image human tissue in vivo in accordance with a protocol 
approved by the Rice University Institutional Review Board. Following topical 
application of medical-grade acriflavine (0.05% in saline), the distal tip of the fiber-optic 
bundle was placed in contact with the normal oral mucosa of a human volunteer. Strong 
uptake of the fluorescent label is indicated in images by the bright appearance of nuclei 
and visibility of cell membranes (Figure 3-5 (a)). While this image and those shown in 
Figure 3-4 were acquired with a scientific-grade CCD camera, we also demonstrated the 
ability of the system to obtain high-resolution images using a low-cost, standard CCD 
camera. An image of the same in vivo tissue is shown in Figure 3-5(b), with cell nuclei 
still apparent. 
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Figure 3-5: In vivo human tissue imaging, (a) Fiber microendoscopy imaging of normal 
human oral mucosa in vivo, following topical application of fluorescent acriflavine 
neutral (0.05% in saline). This image was acquired with a scientific-grade CCD camera, 
(b) Image of the same tissue acquired with a standard CCD camera. In both images, cell 
nuclei appear bright surrounded by dark cytoplasm. Scale bars represent 100 um. 
3.5 Discussion 
As optical contrast agents capable of indicating the onset of disease at the 
molecular level transition to pre-clinical and clinical use, techniques for imaging tissue at 
the sub-cellular level in vivo become increasingly relevant. We have developed a fiber-
optic microendoscopy system, based around a flexible, 1 mm diameter fiber bundle 
which can either be placed in direct contact with the site to be imaged, or introduced 
through a 16-gauge needle for insertion into tissue. The field-of-view and spatial 
resolution are limited by the physical properties of the fiber bundle; namely the diameter 
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and fiber-to-fiber spacing, which for the system presented here are 750 um and < 4 um 
respectively. For a particular bundle, field-of-view and spatial resolution can be traded-
off against each other through the use of additional magnifying lens elements at the distal 
tip [80, 86, 87]. This system uses a single LED for fluorescence excitation, and a color 
CCD camera for image acquisition, enabling multiple fluorescent labels to be visualized 
in real-time. The utility of imaging with multiple spectral channels was previously 
demonstrated in fiber bundle confocal imaging of cells labeled with nuclear and 
cytoplasm-specific fluorophores [80, 82]. Here, we used the CCD's built-in Bayer mask 
to efficiently image three spectral channels simultaneously with a single camera. 
Two cameras were evaluated in this study; a scientific-grade cooled CCD 
(Retiga), and a standard analog CCD (JAI). Both cameras were shown to be capable of 
sub-cellular resolution imaging, but the direct comparison shown in Figure 3-5 reveals 
differences in image appearance that can be related to camera specifications and the 
experimental configuration. Sampling at the tissue specimen is determined by the 
physical spacing of individual fibers in the bundle for direct contact imaging, or the 
demagnified spacing of these same fibers when an additional objective lens is used at the 
distal tip. The image appearing at the proximal end of the bundle is then relayed to the 
CCD camera with magnification factor M set by the objective - tube lens combination. 
For a particular bundle, the number of camera pixels sampling each fiber depends on both 
the CCD pixel size, and relay magnification, M. We summarized these spatial parameters 
in Table 3-1. With the JAI camera, the image of each fiber in the bundle spans 1.6 pixels 
at the CCD sensor, compared to 3.4 pixels per fiber with the Retiga device. So while 
sampling at the specimen is identical for each camera, the spatial sampling frequency for 
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the intermediate image (at the proximal end of the bundle) is over a factor of two higher 
with the Retiga CCD and above the Nyquist requirement, resulting in image resolution 
limited by optical rather than sampling conditions. Intensity resolution is the second 
factor expected to influence image contrast. While both CCDs were digitized at 8-bit 
resolution, the higher dynamic range and lower noise figure for the scientific-grade 
camera results in the least significant bit corresponding to a level times 8.8 times higher 
than the read noise in the Retiga CCD, compared to only 1.2 times for the JAI camera. 
Wide-field fluorescence imaging through a fiber bundle or "image conduit" has 
been reported previously [47, 50, 79], with the reduction in optical sectioning strength 
shown to result in increased collection of background light and reduced image contrast, in 
comparison with truly confocal techniques [79]. Preliminary tests using a planar 
fluorescent sample indicated that the fluorescent signal for our system is predominantly 
collected from a depth of some tens of microns, corresponding to a few cell layers of 
thickness. However, we have shown here that high-quality images with sub-cellular 
resolution can nevertheless be obtained with a system that is simple and relatively 
inexpensive to construct, and robust in operation. Two factors appear to be largely 
responsible for the high image quality. First, contact imaging inherently eliminates 
background light that would be generated between the sample surface and the object 
plane in confocal imaging, and second, use of highly specific, bright fluorophores enables 
the necessary contrast to be generated between cellular components. 
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3.6 Conclusion 
We have presented a high-resolution, wide-field fluorescence imaging system 
based on LED illumination, CCD camera detection, and a 1 mm diameter, flexible fiber-
optic bundle. The sub-cellular resolution color imaging capabilities were demonstrated in 
a series of experiments intended to highlight potential application areas in current clinical 
practice, and in future applications involving molecular-targeted optical contrast agents. 
The ability to obtain information from multiple tissue sites over an extended period of 
time may reduce the inherent uncertainties in point sampling associated with 
histopathology, and provide additional information on specific molecular expression and 
activity, biological processes, and an individual's response to treatment. The instrument 
retains several of the advantageous features of confocal microscopy, including fiber-optic 
delivery, real-time image acquisition, and color multiplexing capabilities. In addition, due 
to its relative simplicity, the instrument is compact, robust, and inexpensive, features 
which are increasingly valuable in both the research laboratory and clinical setting. 
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Chapter 4: Detection of oral squamous neoplasia with a high-
resolution fiber optic microendoscope 
4.1 Abstract 
Purpose: The development of oral neoplasia is associated with changes in epithelial cell 
morphology and architecture, which are usually documented by histologic assessment of 
mucosal biopsy. The goal of this study was to evaluate the ability of high-resolution 
optical microscopy to image and quantify the cellular and architectural features of oral 
neoplasia without the need for biopsy. 
Experimental Design: A high-resolution microendoscope (HRME) was used to image 
intact, resected oral squamous carcinoma specimens following topical application of a 
fluorescent contrast agent. HRME images were reviewed and classified as non-neoplastic 
(normal squamous epithelium and mild dysplasia) or neoplastic (moderate dysplasia, 
severe dysplasia, and invasive squamous carcinoma) by expert clinicians and untrained 
observers. In addition, quantitative features were calculated from each image and used to 
classify images. Results of both visual image interpretation and objective classification 
were compared to the gold standard of histopathologic diagnosis. 
Results: HRME images were obtained from 141 sites in resected specimens from 13 
patients. Subjective image interpretation yielded sensitivity and specificity of 
approximately 85 to 90% and 80 to 85%, respectively, with expert observers 
demonstrating improved specificity compared to untrained observers. The objective 
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classification algorithm achieved sensitivity and specificity of 85% and 78% respectively; 
the area under the receiver-operator characteristic curve was 0.88. 
Conclusions: High resolution optical imaging can image histologic features of oral 
neoplasia without the need for biopsy; both subjective image interpretation and objective 
image analysis yield information useful for classifying oral neoplastic lesions. 
4.2 Introduction 
In the U.S., the overall five-year-survival rate for patients with squamous 
carcinoma of the oral cancer is only 54%, one of the lowest rates of all major cancers; in 
developing countries survival rates drop below 30% [88, 89]. Patients with early lesions 
have better chances for cure and less treatment-associated morbidity, yet despite the easy 
accessibility of the mouth, most patients present with advanced tumors, when treatment is 
more difficult, more expensive and less successful compared to earlier interventions [90]. 
Improved screening and early diagnosis of oral cancer could benefit the global population 
substantially. 
Optical imaging technologies have the potential to improve early detection of oral 
neoplasia; optical technologies can non-invasively assess the morphologic and 
biochemical changes associated with the development of precancer and cancer in real 
time at the point-of-care [91, 92]. Widefleld optical imaging of broad areas of oral 
mucosa could enable clinicians to determine optimal sites for pinpoint probe 
interrogation and/or biopsy, reducing the chance of sampling error [93, 94]. High 
resolution optical imaging can be used to directly visualize changes in epithelial 
morphology in suspicious regions of tissue [42, 95]. Driven by advances in consumer 
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electronics, high quality optical images can now be obtained with low cost devices; 
tandem advances in digital signal processing provide the ability to automate image 
analysis. These advantages have the potential to improve screening, in settings ranging 
from tertiary care centers to regions with limited personnel and infrastructure. 
A number of studies have explored the use of high resolution optical imaging for 
improved detection of oral neoplasia [96, 97]. Reflectance confocal microscopy has been 
used to image changes in cell and nuclear morphology, nuclear to cytoplasmic ratio, and 
epithelial architecture associated with early oral neoplasia [98]. A fiber optic reflectance 
confocal microscope, comprising a single optical fiber and a resonating tuning fork at the 
distal tip, has been integrated into an endomicroscope platform to enable high resolution 
fluorescence imaging of suspicious lesions in the oral cavity [99]. Fiber optic systems 
have also been developed to perform in vivo confocal fluorescence microscopy imaging. 
One such device, the cellVizio (Mauna Kea Technologies, Paris, France) uses a 
galvanometric scanner to raster scan laser light across the proximal tip of a coherent fiber 
bundle to enable confocal fluorescence imaging of tissue at the distal tip of the device. 
This technique has been used successfully to image gastrointestinal and respiratory 
epithelium and other tissues in vivo [100, 101]. While these fiber optic confocal 
microscopes can obtain high resolution images of tissue in real time, they are technically 
complex and expensive. 
An alternative to confocal microscopy is high resolution microendoscopy [29, 
73]. The high-resolution micoendoscope (HRME) uses a coherent fiber bundle to obtain 
high resolution fluorescence images of the tissue in contact with the distal tip of the 
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device without the need for complex mechanical scanning systems and associated control 
electronics [102, 103]. The system uses a low-cost LED to provide illumination and a 
consumer-grade CCD camera to capture high resolution digital images on a laptop 
computer. 
A topically applied fluorescent dye, proflavine, is used to preferentially stain cell 
nuclei. Proflavine is an acridine-derived dye which binds to DNA in a reversible and 
non-covalent manner by intercalating between base pairs [104, 105]. Proflavine has been 
safely used for years as one of the main component of triple dye, applied to the umbilicus 
of newborns to prevent infection [106]. In addition, a number of in vivo imaging studies 
have been performed using topically delivered proflavine as a contrast agent [44, 107]. 
The ability to stain epithelial cell nuclei is useful for precancer and cancer imaging 
applications since it allows for visualization of features such as nuclear-to-cytoplasmic 
ratio. Because digital images are acquired, quantitative analysis of this and other image 
metrics can be easily performed to aid in image analysis [85]. 
The goal of this study was to evaluate the ability of high resolution 
microendoscopy to detect oral neoplasia. HRME images from each site were analyzed 
qualitatively by visual inspection and quantitatively using digital image analysis 
algorithms to determine whether the imaged site contained neoplastic tissue. Results of 
image analysis were compared to the gold standard of histopathology to assess the ability 
of HRME to correctly identify the presence of neoplasia. 
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4.3 Methods 
4.3.1 Patients and data collection 
Patients over 18 years of age scheduled for surgery to remove a previously 
diagnosed oral squamous carcinoma or dysplasia were eligible to participate in the study. 
Informed consent was obtained from all study participants, and the study was reviewed 
and approved by the Institutional Review Boards at the University of Texas M. D. 
Anderson Cancer Center and Rice University. Subjects underwent standard-of-care 
surgery to remove neoplastic oral lesions and associated margins. Following surgical 
resection, the tumor specimen was taken to the lab for imaging. 
A solution of Proflavine (Sigma-Aldrich) dissolved in water at a concentration of 
0.01% (w/v) was prepared prior to performing imaging. The contrast agent solution was 
directly applied to the epithelial surface of the resected tissue with a cotton tipped swab, 
and imaging with the HRME device was performed immediately. The application of 
proflavine does not discolor the tissue surface, and is not detectable in tissue slides 
prepared using standard histopathology processing and H&E staining (Figure 4-1). 
After imaging, the tissue was returned for standard histopathology processing, and 
slides were later reviewed by a board-certified pathologist (M.D.W.). Photographs of the 
gross specimens were obtained before and after placement into individual specimen 
cassettes and were used to obtain histopathologic diagnoses for each of the sites imaged 
with the HRME. At each site imaged, the pathologic diagnosis was determined, using 
five diagnostic categories (normal, mild dysplasia, moderate dysplasia, severe dysplasia, 
and cancer). 
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4.3.2 HRME System 
The HRME device has been previously described in detail [102]. Briefly, images 
are acquired with this device by placing the tip of the fiber bundle into direct contact with 
the epithelial surface of the tissue. Excitation light from a blue LED with a center 
wavelength of 455 nm is delivered through the fiber bundle. The fluorescence emission 
from the topically applied proflavine is collected through the fiber bundle, focused onto a 
CCD camera, and a digital image is stored for future processing and analysis. The HRME 
system has a circular field of view with a diameter of 750 microns; the lateral spatial 
resolution of the system is approximately 4 microns. 
4.3.3 HRME Image Analysis 
HRME images were reviewed to determine whether the endoscope tip was in 
contact with the tissue surface or whether the probe tip moved during image acquisition. 
Images showing such artifacts were discarded and not used in subsequent analyses. 
HRME images passing quality control were reviewed by a group of three expert 
and two non-expert observers. Expert observers included Head and Neck Pathology 
Fellows from the University of Texas M.D. Anderson Cancer Center, while non-expert 
reviewers included graduate students from the Department of Bioengineering at Rice 
University. Reviewers were first shown a small number of HRME images of the oral 
cavity acquired previously from sites with known histopathology; this training set 
consisted of images from 5 pathologically normal and 5 pathologically neoplastic 
measurement sites. Reviewers were subsequently asked to rate HRME images from all 
study sites; for each measurement, the observer was asked to rate the image on a five-
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point scale, with 1 being "definitely non-neoplastic," 2 being "probably non-neoplastic," 
3 being "unknown," 4 being "probably neoplastic," and 5 being "definitely neoplastic." 
The analysis of the subjective scoring was performed identically and separately for 
results from each of the two groups of observers. 
To evaluate the accuracy of qualitative image interpretation, a 5-point receiver-
operator characteristic (ROC) curve was calculated, comparing the results of HRME 
image analysis to that of the gold standard of histopathology. To construct the ROC 
curve, the threshold for qualitative image analysis to be considered abnormal was varied 
from 1 to 5. The subjective rating at each measurement site was compared to this 
threshold; if the subjective rating was greater than or equal to the threshold, the image 
interpretation was considered "neoplastic." Otherwise, the image interpretation for the 
measurement was considered "non-neoplastic." This result was compared to the 
histopathology-confirmed diagnosis, sensitivity and specificity were calculated, and a 
five point ROC curve was constructed for each observer. Sites with a pathologic 
diagnosis of normal or mild dysplasia were considered to be non-neoplastic, while sites 
with a pathologic diagnosis of moderate dysplasia, severe dysplasia or cancer were 
considered to be neoplastic. 
To pool the results of the non-expert group, a majority voting scheme was used to 
construct a single ROC curve. For a given threshold, the "non-neoplastic" or 
"neoplastic" image interpretation was noted for each observer at each site. Since there 
were an odd number of observers in the non-expert group, the pooled interpretation was 
considered to be the most frequent interpretation. This result was compared to the 
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histopathology-confirmed diagnosis, sensitivity and specificity were calculated, and a 
pooled, five-point ROC curve was constructed. 
We explored the diagnostic ability of quantitative image analysis. A rectangular 
region of interest (ROI) was selected from the image of each independent site; ROIs were 
chosen from areas of the image illustrating cellular detail, when present. The ROIs from 
each image were then used in the following quantitative analysis. Fifty-nine distinct 
features were computed for each ROI (Table 4-1). First-order statistical features 
(variance, entropy, etc.) were calculated directly from the grayscale pixel values. A gray-
level co-occurrence matrix (GLCM) with pixel offsets from 1 to 10 was used to calculate 
additional textural feature groups (correlation, contrast, homogeneity, and energy) [108]. 
Each GLCM feature group contained 10 distinct features, for each pixel offset within the 
GLCM. To detect nuclear features, an extended regional maximum transform was 
applied to the image. Voronoi tessellations were calculated from the centroids of the 
nuclear features to calculate internuclear distances [85]. A Fourier transform was applied 
to the ROI to calculate the power spectrum of the image; this was divided into 10 units to 
represent the frequency components of the image [109, 110]. 
A diagnostic algorithm was used to classify each ROI as non-neoplastic or 
neoplastic based on these image features. Histopathology was used as the gold standard; 
sites with a pathologic diagnosis of normal or mild dysplasia were considered to be non-
neoplastic, while sites with a pathologic diagnosis of moderate dysplasia, severe 
dysplasia or cancer were considered to be neoplastic. The classifier was based on two-
class, linear discriminant analysis; a sequential forward feature-selection algorithm 
initially was used to select the best performing subset of up to 10 image features to 
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classify the data. Initially, the best performing single feature was identified, and then 
subsequent features were selected which gave maximum performance when combined 
with previously selected features. The algorithm was developed using five-fold cross-
validation; each measurement site was initially randomly assigned to one of five groups. 
Four-fifths of the data were then used to train the linear classification algorithm and the 
remaining one fifth of the data were used to test the algorithm. This cycle was repeated 
four additional times so that the algorithm was tested using data from each site. 
Performance was monitored by calculating the area under the curve (AUC) of the 
classifier. 
Alternatively, three-class diagnostic algorithms were developed to classify each 
ROl as: (1) normal or mild dysplasia, (2) moderate or severe dysplasia, and (3) cancer. 
Both linear discriminant analysis and a categorical tree-based classifier were used [111, 
112]. The linear discriminant algorithm was trained using five-fold cross validation,as 
described above. Sequential feature selection was performed in each training fold, 
choosing the best performing pair of features. A categorical tree classifier was also 
allowed to choose among the entire feature set. The tree classifier was directed to choose 
the top performing two-feature feature subset while performing classification on the 
entire data set, and was pruned to three terminal nodes to avoid overtraining. The 
predicted classification results from each classifier were then compared to the 
histopathology for each site. 
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4.4 Results 
4.4.1 Patients and Sites: 
Thirteen subjects enrolled in the study. Images were obtained from 150 unique 
sites; images from 141 of these sites passed the QC review and were used for further 
analysis. Of these 141 sites, 40 were histologically confirmed to be normal squamous, 11 
were mild dysplasia, 11 were moderate dysplasia, 12 were severe dysplasia, and 67 were 
invasive squamous carcinoma. Figure 1 shows representative HRME images (top row) of 
/ x ^ 
>*M: 
mmm^ •K 
Normal Dysplasia Cancer 
Figure 4-1: Illustration of HRME images (top row) compared to H&E images (bottom 
row). From right to left, diagnostic categories are: normal squamous mucosa, moderate 
dysplasia, and invasive squamous carcinoma. All images are sized to the same scale; 
scale bar represents 100 (xm. 
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non-neoplastic, moderate dysplasia, and invasive cancer, respectively. Histopathology 
images can be seen below. All images are at the same scale for comparison. The HRME 
image of normal squamous epithelium shows small, bright nuclei with dark cytoplasm 
and relatively large internuclear separation. The image of dysplastic epithelium shows a 
marked increase in nuclear-to-cytoplasmic ratio, and the image from invasive carcinoma 
shows a distinct loss of cellular organization and internuclear separation. 
Feature 
Entropy 
Correlation (10) 
Variance 
Standard Deviation 
Energy (10) 
Kurtosis 
Homogeneity (10) 
Skewness 
Contrast (10) 
Std. Dev. Nuclear 
Separation Distance 
Frequency (10) 
Mean Nuclear 
Separation Distance 
Mean Minimum 
Nuclear Separation 
Distance 
Nuclei Per Unit Area 
Explanation 
Statistical measurement of randomness of grayscale values 
Pixel neighbor correlation overthe entire image 
Variance of pixel grayscale values 
Standard deviation of grayscale values 
Sum of squares in gray-level co-occurrence matrix (6LCM) 
Measure of theflatness of the pixel value distributions 
Closeness of the distribution of the GLCM elements to the diagonal 
Measure of the symmetry of the pixel value distribution 
Measure of pixel intensity compared to its neighbors overthe entire 
image 
Standard deviation of nuclear separation as calculated by Voronoi 
tessellation 
Frequency distribution of pixel values 
Mean nuclear separation as calculated by Voronoi tessellation 
Average minimum nuclear separation as calculated by Voronoi 
tessellation 
Number of nuclei detected divided by area of region of interest 
Table 4-1: Quantitative image features. The table is in order of performance as 
roughly estimated by a linear discriminant analysis using the entire data set for 
training and testing. 
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4.4.2 Subjective image interpretation: 
Figure 2(a) shows the ROC curve for each of the non-expert observers and for the 
pooled non-expert group. Performance was improved when scores were combined using 
a voting scheme. Figure 2(b) shows the ROC curve for each of the expert observers and 
for the pooled expert group. The performance of both groups is qualitatively similar, but 
expert clinicians outperformed the untrained observers. In particular, expert clinicians 
appeared to have better sensitivity at distinguishing normal from abnormal groups than 
untrained observers. 
Non- Expert Subjective Scoring ROC 
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Figure 4-2: Subjective image analysis receiver-operator characteristic (ROC) curves. 
Left, non expert individual and pooled results (solid line). Right, expert individual results. 
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4.4.3 Quantitative image feature calculation 
A representative image showing the rectangular region of interest (ROI) selected 
from the HRME image from a site with a pathologic diagnosis of invasive carcinoma is 
shown in Figure 4-3a; the ROI was selected from the region of the image with easily 
recognized cell nuclei. Quantitative image features calculated from the ROI from each 
site were ranked according to their diagnostic ability. Image features in Table 4-1 are 
listed in order of descending area under the ROC curve for the single-feature, two-class 
linear discriminant analysis classifier. The single best performing feature was found to 
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Figure 4-3: Quantitative analysis. 4-3a. Illustration of ROI selection; note 
region containing visible cell nuclei selected by the observer. 4-3b. Box 
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plot showing the classification utility of entropy as a single feature. Note 
the separation between normal squamous and mild dysplasia compared to 
moderate and severe dysplasia and cancer. 4-3c. Measurement sites plotted 
using two features. Non-neoplastic sites are plotted as blue squares, 
neoplastic sites are plotted as red crosses. The decision line is shown. 
be the entropy value of the ROI. Figure 4-3b shows a box plot representing the entropy, 
averaged for each of the five histopathologic categories. On average, the entropy is 
higher for sites with moderate dysplasia, severe dysplasia and cancer than for normal 
sites or sites with mild dysplasia. 
The top performing combination of two features was found to be entropy and the 
pixel pair correlation probability. Figure 4-3c shows a scatter plot of these two features 
for each of the 141 sites in the dataset. Samples with a pathologic diagnosis of normal or 
mild dysplasia are shown as blue squares, while samples with a pathologic diagnosis of 
moderate dysplasia, severe dysplasia or cancer are shown as red crosses. 
Figure 4-4a shows the AUC as a function of the number of image features 
selected in the linear discriminant algorithm. AUC increases from one to two features, 
but is not improved by addition of more features. Therefore, only two features were used 
to train the linear classification algorithm. Figure 4-4b shows a scatter plot of the 
posterior probability that each site is neoplastic as calculated by the linear classifier; 
samples are grouped by histopathologic diagnosis. Figure 4-4c shows the ROC curve for 
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the linear discriminant classifier based on these two features. The AUC is 0.88 and the 
sensitivity and specificity at the Q-point are 85% and 78%, respectively. 
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Figure 4-4: Classification performance. 4-4a. Calculated classification 
performance versus number of features used; note the plateau at two features. 
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4-4b. Scatter plot of calculated posterior probability generated by a two-
feature linear discriminant analysis (LDA) algorithm. The decision is shown 
at 0.46. 4-4c. ROC curve of calculated classification performance using the 
two-class, two-feature LDA. The Q-point is shown corresponding to a 
sensitivity of 85% and a specificity of 78%. 
Normal 
(predicted) 
Dysplasia 
(predicted) 
Cancer 
(predicted) 
Linear Classifier 
Normal Dysplasia 
(true) (true) 
67 9 
16 68 
17 23 
Cancer 
(true) 
13 
24 
63 
Normal 
(predicted) 
Dysplasia 
(predicted) 
Cancer 
(predicted) 
Tree-based Classifier 
Normal 
(true) 
67 
6 
27 
Dysplasia 
(true) 
13 
30 
57 
Cancer 
(true) 
3 
6 
91 
Table 4-2: Three-class algorithm results. 
Table 4-2 summarizes the performance of both three-class algorithms. The tree-
based classification algorithm selected pixel correlation and entropy as features; pixel 
correlation was used to separate cancer from normal and dysplasia, while entropy was 
used to separate normal and mild dysplasia from moderate and severe dysplasia. The 
same features were selected for the linear three-class classifier. The linear classifier 
correctly predicted the class for 67% (normal), 68% (dysplasia), or 63% (cancer) of the 
measurement sites. In comparison, the tree-based classifier had the same performance for 
discriminating normal measurements, but had a high false-positive rate for classifying 
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dysplasia (incorrectly predicting 57% of dysplasia sites to be cancer). The tree-based 
classifier performed well when discriminating cancer measurement sites (91% correct). 
4.5 Discussion 
This study demonstrates the use of a robust, high-resolution microendoscope to 
image cellular and architectural features of oral neoplasia. Both subjective visual 
interpretation of images and objective analysis of digital images can differentiate non-
neoplastic and neoplastic oral mucosa with high sensitivity and specificity relative to the 
gold standard of histopathology. 
While these results are encouraging, there are a number of limitations associated 
with HRME imaging. The surface imaging strategy employed by this device cannot 
image submucosal tumors. In addition, significant hyperkeratosis or superficial necrotic 
debris may also preclude visualization of the cell layers that lie beneath. These limitations 
can potentially be overcome by one of two strategies: optical sectioning or mechanical 
penetration into deeper tissue. Optical sectioning, as used in confocal microscopy, 
enables an optical device to collect high-quality images from several hundred microns 
below the tissue surface [99, 113, 114]. Alternatively, the fiber optic bundle used in the 
HRME is less than 1 millimeter in diameter, and can be inserted through the lumen of a 
16 gauge hypodermic needle. In this fashion, the tip of the image guide can be directly 
inserted into deeper tissue, avoiding any keratin or debris layer at the surface. Such a 
technique has been previously demonstrated in an in vivo imaging study of a 
subcutaneous oral squamous carcinoma xenograft tumor [102]. 
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The ability of the HRME to image subcellular features of neoplasia could have a 
number of clinical applications. Tumor margin detection during surgical removal is 
essential to minimize the chances of recurrence [115, 116]. HRME imaging could be 
used to provide high-resolution information of the tissue margins to the surgeon as the 
procedure is taking place. Nearly-instantaneous return of high-resolution information can 
be clinically significant for both screening and margin-detection in the operating room, 
and could be used as a complement to current frozen section histopathology [117]. 
Mapping the extent of a tumor while performing the surgical removal of a tumor could be 
of great benefit in assuring that no abnormal tissue remains. 
In addition to being well-suited as an intra-operative margin detection tool, the 
HRME shows potential as an oral cancer screening tool, particularly in combination with 
other widefield imaging techniques. One of the limitations of the HRME is that only a 
small FOV can be sampled at a time. By combining this technology with a widefield 
imaging device, which can quickly collect data from the entire oral mucosa, the potential 
exists to increase the sensitivity and specificity obtained with either device alone. 
Suspicious lesions exhibiting a loss of autofluorescence signal strongly correlate with 
dysplasia and cancer with high sensitivity and specificity. This loss of fluorescence in 
wide field imaging has been postulated to be due to a loss of collagen crosslink 
fluorescence [118]. It is currently unclear whether a significant loss of fluorescence can 
also occur in the presence of benign conditions such as inflammation. A small, flexible 
point probe imaging system would be an asset in distinguishing the difference between 
benign and malignant lesions and help guide further diagnostic workups. Any lesion 
exhibiting a loss of autofluorescence as seen with a wide field imaging modality could be 
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quickly inspected with the HRME probe. Instantaneous feedback to the surgeon would 
then guide further workup for the patient. 
The HRME represents a low-cost and more robust alternative to confocal imaging 
systems, ideally suited to a region where high turnover and poor patient follow-up occurs. 
In addition, by using a quantitative algorithm to aid in discriminating between different 
tissue types, the need for highly trained expert operators is reduced. This device is well 
suited as a complement to other widefield imaging techniques for early detection of 
cancer in the oral cavity. Collecting such instantaneous high-resolution image data of 
suspicious lesions can speed the diagnosis of malignant or premalignant lesions that can 
are candidates for surgical resection. 
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Chapter 5: Widefield multispectral imaging and high-resolution 
microendoseope imaging for detection of oral neoplasia 
5.1 Introduction 
Squamous carcinoma of the head and neck is associated with poor five-year 
survival, usually a consequence of late-stage disease at diagnosis [119]. Treatment of oral 
cancer is associated with severe morbidity; surgical removal of oral tissue often results in 
disfigurement and impairs speech and the ability to swallow. Diagnosis of head and neck 
cancers at an earlier stage can improve reduce morbidity and improve efficacy of therapy, 
leading to improved patient survival and quality of life. 
The current standard-of-care to screen for oral cancer is white light inspection of 
the oral cavity by an expert clinician, followed by biopsy and histologic analysis of 
suspicious lesions. Subjective visual examination requires adequately trained personnel, 
as well as the availability of histopathology labs to analyze biopsy specimens of 
suspicious lesions. Even in developed nations, lesions are commonly not discovered until 
a late stage because of the relative lack of screening. 
Optical methods offer a means to improve screening for oral neoplasia at the point 
of care without the need for extensive infrastructure. Autofluorescence visualization is a 
promising tool to detect early neoplastic changes in the oral epithelium. The Velscope is 
a commercial system that uses blue light to excite autofluorescence in the oral mucosa; a 
3
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clinician can then visually inspect the mucosa and identify suspicious areas based on loss 
of autofluorescence [93,120]. It has been demonstrated that precancer and cancer are 
associated with loss of stromal collagen fluorescence [121]. 
Computer-aided tools and quantitative classification algorithms can be used to 
further improve the screening process and provide an objective diagnosis. Digital 
imaging of the autofluorescence signal from the oral mucosa allows quantifiable image 
parameters to be calculated; the red-to-green pixel intensity ratio has been of particular 
importance in distinguishing between neoplastic and non-neoplastic sites. A recent study 
by our group using this technique achieved a sensitivity of 100% and specificity of 91.4% 
in an independent validation data set [122]. 
A potential limitation of widefield imaging and analysis of the bulk tissue 
autofluorescence signal is that this modality does not directly sample some of important 
pathologic features, such as changes in cellular and nuclear morphology. High-resolution 
imaging may be used to complement the diagnostic capability of widefield imaging. 
High-resolution imaging can be used to directly observe changes in epithelial cell 
morphology and epithelial architecture over small fields-of-view. These changes include 
increased nuclear-to-cytoplasmic ratios, pleomorphism, and alterations in the gradation of 
cellular differentiation throughout the epithelium. A variety of high resolution optical 
imaging modalities are available to sample these morphologic and architectural changes, 
including confocal micrscopy, optical coherence microscopy and high resolution 
microendoscopy [82,114, 123]. 
Multimodal imaging approaches which combine images from wide field and high-
resolution modalities have the potential to improve early detection of neoplastic changes. 
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Wide field imaging allows for rapid inspection of nearly the entire oral cavity, while 
high-resolution imaging can be used to interrogate suspicious regions with higher spatial 
resolution. 
The goal of this study was to explore the complementary diagnostic ability of 
widefield autofluorescence imaging ad high resolution microendoscopy for early 
detection of oral neoplasia. Widefield autofluorescence images were obtained from 
resected oral tumors; high resolution images were then obtained following topical 
application of a fluorescent contrast agent to visualize changes in nuclear morphometric 
and density. The ability to classify oral tissue as normal or neoplastic was explored 
using data from widefield imaging along, high resolution imaging alone and the 
combination of the two modalities. Multimodal approaches yielded the greatest 
sensitivity and specificity relative to the gold standard of histopathology, supporting the 
complementary role of these two imaging approaches. 
5.2 Methods 
5.2.1 Data Acquisition and Instrumentation 
Data was collected under a clinical protocol approved by the Institutional Review 
Boards at the University of Texas MD Anderson Cancer Center and Rice University. All 
participating subjects gave written informed consent. Patients were eligible if they were 
18 years old or older and were scheduled for surgical resection of a known precancerous 
or cancerous lesion in the oral cavity. 
Following resection, tissue was imaged in the laboratory using first a widefield 
multispectral digital microscope (MDM) and then a high resolution microendoscope 
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(HRME) system. The MDM is described in detail elsewhere [94]. Briefly, the MDM 
system is a modified clinical microscope which collects digital images with an 
approximate 5 cm by 7 cm field of view (FOV). The system is capable of collecting data 
in several different imaging modalities but for this study only white light reflectance and 
autofluorescence images at 405 nm excitation were utilized. The entire mucosal surface 
of the resected tissue was imaged using the MDM. 
The HRME system is described in detail elsewhere [103]. Briefly, the system can 
image cellular detail of the upper epithelium by placing a fiber optic image guide guide 
into direct contact with the tissue. Contrast is achieved by applying a topical solution of 
proflavine (0.01% in water) with a cotton swab immediately before imaging. Proflavine 
is a fluorescent agent that binds to DNA, yielding bright nuclei surrounded by dark 
cytoplasm. The HRME system uses an LED with a center wavelength of 455 nm as an 
excitation source; this is directed through an objective lens and coupled to the fiber optic 
image guide, which delivers it to the tissue surface. Fluorescence emission light travels 
back though the image guide, is magnified by the objective lens, and is imaged to a CCD 
camera, where it is digitally stored and sent to a PC. The HRME system has a circular 
field of view with a diameter of 750 microns, and collects image data at 4 frames per 
second. 
Both clinically normal and suspicious areas were measured with both the MDM 
system and the HRME system. Several suspected non-neoplastic and neoplastic sites 
were imaged on each resected specimen. HRME images were qualitatively assessed by 
the authors (TJM and DMR) for the presence of nuclear detail. Only HRME images 
which revealed nuclear detail were included in this study. For each interrogated tissue 
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site, one or more HRME images were collected inside a small, approximately 2 
millimeter diameter area. 
Histopathology diagnosis was obtained from the sites imaged with the MDM and 
HRME. The locations of regions imaged with the HRME were recorded using digital 
photography, and these locations were tracked throughout histopathology processing. 
The resected tissue was sectioned and stained according to standard histopathology 
practice and diagnosis was obtained from prepared slides by an expert Head and Neck 
pathologist (M.D.W.). 
5.2.2 Computer Aided Diagnostics 
Image data obtained with both the MDM and HRME were used to develop 
objective classifiers to identify neoplastic tissue. Images from each device were first 
processed and used to train a linear discriminant classifier based on a single imaging 
modality. MDM and HRME results were then combined using multiple hybrid 
consensus techniques to train multimodal classifiers. Tissue sites imaged with both the 
MDM and HRME and with a corresponding pathologic diagnosis were included in this 
analysis. 
For analysis of MDM data, circular regions of interest (ROIs) with a 20 pixel 
diameter, which correspond to an approximate 1mm diameter circular region of tissue, 
were selected from MDM images at sites imaged by the HRME. In addition, a 
normalization ROI was identified in each specimen from a pathologically normal area, 
distant from any lesion. Features obtained from the pixel values inside these regions 
were then extracted. Previous in vivo studies have shown that the mean ratio of red to 
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green autofluorescence at 405 nm excitation, normalized to a known non-neoplastic 
region, provides a high degree of discrimination between non-neoplastic and neoplastic 
tissue [122, 124]. This feature was extracted from the ROIs of MDM images collected in 
this study; these values were normalized by the mean red to green autofluorescence ratio 
from the normalization ROIs. 
This feature was used as input to a 2-class linear classifier based on Bayesian 
parameter estimation in order to obtain a predicted diagnosis of either non-neoplastic or 
neoplastic. The neoplastic class includes ROIs with diagnoses of mild, moderate, and 
severe dysplasia as well as carcinoma in situ and invasive carcinoma. The non-neoplastic 
class included epithelial tissue which was histopathologically normal with or without 
hyperplasia, hyperkeratosis, or inflammation. Leave-one- patient-out cross-validation 
was used avoid overtraining the algorithm [125]. A posterior probability was obtained 
for each site which is the predicted probability that the site is in the neoplastic class. A 
receiver-operating-characteristic (ROC) curve was generated by changing the threshold 
of the posterior probability value used to determine if a measurement was in the first or 
second class, and then plotting 1 -specificity versus sensitivity at each threshold value or 
operating point. The area under the curve (AUC) of the ROC plot was used as a figure-
of-merit (FOM) to determine classification performance. Sensitivity, specificity, positive 
predictive value, and negative predictive value were also determined at the operating 
point which maximized the sum of sensitivity and specificity and reported. 
A variety of features were extracted from the HRME images at each site and used 
as input to a linear classifier. Regions of interest were manually selected from each 
HRME image, corresponding to regions subjectively showing the most nuclear detail. In 
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addition, this ROI selection was done to eliminate the boundaries of the images, which 
did not contain any information. Features were extracted from these rectangular ROIs. In 
the cases where there was more than one HRME image collected from a site, the mean of 
these feature values was used for classification. First order statistical features such as the 
mean, standard deviation, and entropy of pixel values were extracted from the ROIs. 
Textural features obtained from gray-level co-occurrence matrices with pixel offsets from 
1 to 10 pixels were also obtained. Spatial frequency content features were extracted by 
performing a 2-D Fourier transform on the image data inside the ROIs. Further detail 
about these features is provided in [124]. 
In order to select the most diagnostically valuable features from the HRME data, a 
forward sequential feature selection algorithm was implemented [125]. This algorithm 
tested each feature separately and then in combination using the linear classifier to 
determine the two features which classified the data most accurately based on maximal 
area under the ROC curve. Two features were chosen because adding additional feature 
did not statistically improve classification performance. The HRME data were classified 
using the linear classifier with the two selected features using leave-one-out cross-
validation. Again, a posterior probability was obtained for each site An ROC plot, AUC, 
sensitivity, specificity, positive predictive value, and negative predictive value were 
obtained. 
5.2.3 Combinatorial methods 
Two separate strategies were implemented to combine data from both imaging 
modalities to yield a single diagnosis. The first approach used was to develop a classifier 
70 
using input from both imaging modalities to obtain a single diagnosis. We refer to this 
technique as the Nondirected Combinatorial Technique. The second strategy, referred to 
as the Directed Combinatorial Technique, used data from the MDM to first identify 
potentially neoplastic sites. At these sites, data from both the MDM and HRME 
modalities were used to classify the site as neoplastic or non-neoplastic. The Directed 
Combinatorial Technique was implemented by first using data from the MDM to train 
and test a linear classifier using input from all of the measurement sites. The operating 
point for this classifier was selected such that a sensitivity of 90% was achieved. Sites 
classified as non-neoplastic by this algorithm were not analyzed further. Sites classified 
as potentially neoplastic by this algorithm were analyzed further. A second algorithm 
was developed using both MDM and HRME data from these sites. 
For both the Directed and Nondirected Combinatrorial Techniques, we explored 
eleven different methods to combine the results from two devices. Eight of these 
methods rely on combining the posterior probabilities obtained from each device for each 
site to produce a new metric which can be used to discriminate the classes. Many of 
these methods are described by Bendiktsson et al. [126]. The other three methods 
explored involve utilizing one or more classifiers in a different way, as described below. 
The posterior probabilities (pp) per site were combined from the two devices in 
the following eight ways: 
1. The maximum of the two pp' s was used, 
2. The minimum of the two pp' s was used, 
3. The mean of the two pp' s was used, 
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4. The weighted sum of the two pp's was used where the weights were determined 
heuristically by the relative performance of each device. We have used the AUC 
obtained from each device as the FOM to determine the weights. This method is 
called Linear Opinion Pool (LOP). 
5. The weighted sum of the two pp's (LOP) was used where the weights were 
determined by a search of different weights. The weights of each device were 
between 0 and 1 and the weight from the second device W2, was equal to 1- w/, 
where wi is the weight for the first device. Weights were tested in .01 increments. 
6. The product of the two pp's was used. This method is called Logarithmic Opinion 
Pool (LOGP). 
7. The weighted product of the two pp's (LOGP) was used where the weights were 
determined by a search. The weights were applied as exponents for the pp's. 
8. The weighted sum of the two pp's (LOP) was used where weights were 
determined both per device and per class. This method is described in reference 
[126]. 
In addition to these methods, three other methods were used to synthesize the 
data. The pp from the MDM was used as the prior probability for the HRME linear 
classifier; extracted features from both devices were used in a single linear classifier; and 
the pp from the MDM was used as an additional feature for the HRME linear classifier. 
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5.3 Results 
In total, resected specimens were obtained from 14 patients. Six of the resected 
specimens primarily involved the tongue, three primarily involved the floor of mouth, 
two primarily involved the buccal mucosa, one primarily involved the retromolar trigone, 
one involved the tongue and floor of mouth and one involved the gingiva and floor of 
mouth. From these specimens, 69 unique measurement sites were matched to a 
corresponding pathology diagnosis. These sites included 26 sites with a diagnosis of non-
neoplastic, 3 sites with mild dysplasia, 4 sites with moderate dysplasia, 13 sites with 
severe dysplasia or carcinoma in situ, and 23 sites with invasive squamous cell 
carcinoma. When divided into two classes: the non-neoplastic class contains 26 sites and 
the neoplastic class contains 43 sites. 
A ROI from the MDM autofluorescence images was selected at the each of the 69 
sites. A normalization ROI was chosen for each patient and corresponded to a 
histopathologically normal area. 126 HRME ROIs were obtained from the 69 sites; when 
multiple ROIs were available, the features were averaged together. 
Figure 5-la shows a representative MDM autofluorescence image at 405 nm 
excitation collected from resected tissue from the floor of mouth. MDM ROIs are 
indicated from a site with squamous cell carcinoma (red circle) and a site which is non-
neoplastic (blue circle). Note the relative decrease in autofluorescence at the carcinoma 
site. Figure 5-lb shows an HRME image collected at the carcinoma site. Figure 5-lc 
shows an HRME image for the non-neoplastic site. Note the nuclear crowding and 
disorganized architecture in 5-lb compared to 5-lc. 
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Figure 5-1: 5-la. MDM Autofluorescence image at 405 nm excitation 
from resected tissue from the floor of mouth. MDM ROIs from a 
squamous cell carcinoma (SCC) site and a non-neopalstic site are 
indicated. 5-1 b. HRME image collected from the SCC site. 5-lc. HRME 
image collected from the non-neoplastic site. 
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Figure 5-2 shows results from the Nondirected Combinatorial Technique where 
data from both devices was used from all measurement sites. Figure 5-2a is a scatter plot 
of normalized red to green ratio per measurement site calculated from MDM images. 
The indicated discrimination line yields a sensitivity of 79.1% and a specificity of 69.2%. 
Figure 5-2b is the ROC curve produced by the linear classifier using this feature alone. 
The indicated operating point corresponds to the discrimination line in Figure 5-2a and is 
located at the Qpoint, the point on the ROC curve which is the minimum distance from 
the upper left hand corner of the plot. Figure 5-2c is the scatter plot of the two selected 
feature values from the HRME. The two features chosen by the sequential feature 
selection algorithm were pixel grayscale variance (a first-order feature) and the pixel pair 
correlation value calculated from the gray level co-occurrence matrix at an offset of 1. 
The indicated discrimination line yields a sensitivity of 69.8% and a specificity of 80.8%. 
Figure 5-2d is the ROC curve produced by the linear classifier using these features. The 
indicated operating point corresponds to the discrimination line in 5-2c and is also at the 
Qpoint. 
Table 5-1 indicates the AUC achieved using each of the 11 methods to combine 
data from the two modalities. Table 5-1 also summarizes the change in AUC for the 
combined modalities relative to the AUC achieved using each device by itself. Method 5 
produces the highest AUC of all of the combination methods. This method highly favors 
the MDM posterior probabilities by a factor of 8. Figure 5-2e shows the ROC curve 
produced using Method 5, the weighted linear opinion pool of posteriors probabilities 
from each device. This combined method produced an AUC of .875, a sensitivity of 
74.4% and a specificity of 87.5%. This AUC is a 10.9% increase of the MDM alone and 
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a 16.4% increase over the HRME alone. The second highest AUC (.824) was produced 
by method 2 where the lower posterior probability was chosen from the devices for each 
measurement site. The third highest AUC (.819) was produced by the weighted product 
of posterior probabilities where the MDM was again weighted highly favorably. 
Combination Method 
i, Maximum posterior probability. 
2. Minimum posterior probability. 
3. Mean posterior probability. 
4. LOP, Weighted sum of posterior probabilities, 
weights determined from individual AUC for devices. 
5. LOP, Weighted sum of posterior probabilities. 
weights determined from search. 
WM»r.W,K'HlalfrM 
6.I.OGP, Product of posterior probabilities. 
7. LOOP, Weighted Product of posterior probabilities, 
weights determined from search. 
W'vffivr'.S?, W'HK4,f=. 13 
8. Weights determined for device and class. 
9. MDM posterior probability used as HRME prior probability. 
10. MDM posterior probability used as feature in HRME classifier. 
11. One classilier using features from both devices. 
AUC 
.794 
.824 
.810 
.772 
.875 
.811 
.819 
.789 
.817 
.784 
.790 
% increase 
over MDM 
.68 
4.4 
2.7 
-2.2 
10.9 
2.8 
3.9 
-.06 
3.5 
-.68 
.It 
% increase 
over HRME 
5.6 
9.6 
7.8 
2.6 
16.4 
7.9 
9.0 
4.9 
8.6 
4.2 
5.1 
Table 5-1: Combinatorial methods and the AUC achieved. Both devices 
were used to measure all measurement sites. The percent increase in AUC 
values over each device alone is shown. Method 5 produced the highest 
AUC. 
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Figure 5-2: Results from the Nondirected Combinatorial Technique. Each 
device was used to measure all of the measurement sites. 5-2a. Scatterplot 
of normalized red to green ratio per measurement site calculated from 
77 
MDM images. The indicated discrimination line yields a sensitivity of 
79.1% and a specificity of 69.2%. 5-2b. ROC curve produced by the 
linear classifier using this feature. The indicated operating point 
corresponds to the discrimination line in 5-2a. 5-2c. Scatter plot of the 
two selected features from the HRME. The indicated discrimination line 
yields a sensitivity of 69.8% and a specificity of 80.8%. 5-2d. ROC curve 
produced by the linear classifier using these features. The indicated 
operating point corresponds to the discrimination line in 5-2c. 5-2e. The 
ROC curves in 5-2b. and 5-2d. with the ROC curve produced by 
combination method 5 in table 5-1: the weighted linear opinion pool of 
posteriors probabilities from each device. 
Figure 5-3 and Table 5-2 show results from the Directed Combinatorial 
Technique. The MDM was first used to identify measurement sites with a sensitivity of 
90.0%. For this analysis however, the closest operating point available from the linear 
classifier trained on the MDM data was at 90.7% sensitivity. The HRME data was then 
used to aid in diagnosis of only these measurement sites. Figure 5-3a is a scatter plot of 
posterior probabilities per measurement site produced from data only from the MDM. 
The indicated discrimination line yields a sensitivity of 90.7% and a specificity of 38.5%. 
Measurements below this line are assumed non-neoplastic. There are 14 measurement 
sites below the threshold, 10 sites are non-neoplastic and 4 are neoplastic confirmed by 
histopathology. HRME data is utilized in the combination methods with measurements 
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above this line. ROC curves and performance metrics were computed from the 
combination of posterior probabilities from all measurement sites. 
Combination Method 
1. Maximum posterior probability. 
2. Mimiraim posterior probability. 
3. Mean posterior probability. 
4. I.OP. Weighted sum of posterior probabilities, 
weights determined from individual AUC lor devices 
5. LOP. Weighted sunt of posterior probabilities. 
weights determined from search. 
"W»sr^89. "J *S«H~I1 
6. MXiP. Product of posterior probabilities. 
7. LCXiP. Weijthted Product of posterior probabilities, 
weights determined from search. 
8, Weights determined for device and class. 
9 MI>M posterior probability used as HIvMK prior probability. 
10. MDM posterior probability used as feature in HRMH classifier. 
11. One classifier using features from both devices. 
AUC 
,83« 
.828 
.832 
832 
847 
.830 
.833 
.82? 
.827 
.809 
.818 
% inc. over 
MOM 
+5.16 
+499 
+5.44 
+5 51) 
+7.37 
+5.22 
+5.56 
+4.82 
+4.88 
+2.58 
+3,74 
Se 
76.7 
76.7 
7*.? 
76 7 
86 1 
76.7 
83.7 
76.7 
76.7 
84.6 
74.4 
% iftc otrer 
MOM 
-14.7 
-14.7 
-14? 
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Table 5-2 : The combinatorial methods and the performance achieved. 
The MDM was used to identify measurement sites with a greater than 
90.7% probability of being neoplastic and the HRME was used to measure 
only these sites. The percent increase in AUC, sensitivity, and specificity 
values over the MDM alone are shown. The sensitivity of the MDM by 
itself was 90.7%, the specificity was 38.5%, and the AUC was .789. 
Method 5 produced the highest increase in AUC. 
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Figure 5-3: Results from the Directed Combinatorial Technique: when the 
MDM is first used to identify measurement sites with a sensitivity of 90%, 
and then the HRME is used to aid diagnosis of these measurement sites. 
5-3a. Scatterplot of posterior probabilities per measurement site produced 
from data only from the MDM. The indicated discrimination line yields a 
sensitivity of 90.7% and a specificity of 38.5%. Measurements above this 
line are tested using the HRME. Measurements below this line are 
assumed non-neoplastic and assigned a posterior probability of 0. 5-3b. 
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ROC curves produced by the MDM alone and from the 2 step method 
described. The AUC increases from .789 to .847 using this two step 
method. The qpoint is indicated on both ROC curves. The operating 
point yielding 90.7% sensitivity is also shown on the ROC produced from 
the MDM alone. 
The highest AUC from the Directed Combinatorial Technique was achieved using 
the weighted linear opinion pool of posteriors probabilities from each device (Table 5-2). 
The same weights used for both the Directed and Nondirected Combinatorial Techniques. 
Figure 3B shows the ROC curves produced by the MDM alone and from the Directed 
Combinatorial Technique. The AUC increases from .789 to .847 using this method. The 
sensitivity drops from 90.7% to 86.1%. The specificity increases from 36.5% to 80.8%. 
The qpoint is indicated on both ROC curves. The operating point yielding 90.7% 
sensitivity is also shown on the ROC produced from the MDM alone. 
The highest AUC produced from the Nondirected Combinatorial Technique was 
.875 whereas the highest AUC achieved from the Directed Combinatorial Technique was 
.847. Data from 14 (20.3%) fewer measurements sites were required from the HRME for 
the Directed Combinatorial Technique. 
5.4 Discussion 
In this study, image data from two optical imaging devices were combined to 
make a quantitative, objective classification algorithm to distinguish between neoplastic 
and non-neoplastic oral mucosa. Both of the combination strategies improved 
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classification performance over either device alone. The non-directed combinatorial 
technique yielded a 10.9% increase in AUC over the MDM alone and a 16.4% increase 
over the HRME alone. In addition to the combination of physically different 
measurement data provided by two different imaging modalities, independent imaging 
systems allow for the development of classification algorithms tailored to provide a 
desired sensitivity or specificity value. The Directed Combinatorial Technique described 
in this paper used the wide field imaging data alone, with a decision line set at 90% 
sensitivity as an initial screen. The abundant false positives remaining after this screen 
were reduced in a second step using combined wide field and high resolution imaging 
data. The selection of 90% sensitivity during the initial screen was made so that most of 
the true positives would be captured while the number of measurements sites to be 
measured by the HRME is reduced. While the final result following the second screen 
did not achieve a 90% sensitivity (impossible unless the second method was able to 
classify with a 100% sensitivity at a nonzero specificity), the combined result still yields 
a significant improvement, 7.4% increase in AUC, over the MDM alone. Additionally, 
the final sensitivity at the Qpoint was higher and more reflective of the initial sensitivity 
threshold for the Directed Combinatorial Technique compared to the Nondirected (86.1% 
sensitivity for the Directed compared to 74.4% for the Nondirected). These results 
compared well to the weighted LOP classification results from the Nondirected 
Combinatorial Technique, but allows the user to better control the desired prediction 
efficiency, and in this case required measurement 20.3% fewer sites with the HRME. 
In a previous in vivo study using the MDM a sensitivity of 100% and specificity 
of 91.4% was achieved for discriminating neoplastic from non-neoplastic tissue [122]. 
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The MDM performance was significantly worse in this study which yielded a sensitivity 
of 79.1% and a specificity of 69.2%. These differences may be due to the changes in 
resected specimens compared to in vivo tissue. Qualitative comparisons of the same 
tissue in vivo and ex vivo show differences in autofluorescence intensity which may 
correlate with the cessation of blood flow and other biochemical changes. Quantitative 
screening tools, such as the combinatorial wide field and high-resolution imaging 
algorithm presented in the text, offers clinicians an objective means of examining the oral 
cavity. Since this technique requires minimal input from the user and a carries a very low 
per-use cost, higher volume and more frequent screening could be implemented, with the 
goal of discovering neoplastic lesions of the oral cavity at an earlier, more treatable stage. 
Such early diagnosis would enable more conservative, tissue-sparing treatment options, 
with a better overall outcome for the patient. 
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Chapter 6: High-resolution imaging in Barrett's Esophagus: a 
novel, low-cost endoscopic microscope4 
6.1 Abstract: 
Background: This report describes the clinical evaluation of a novel, low-cost, high-
resolution endoscopic microscope for obtaining fluorescent images of the cellular 
morphology of the epithelium of regions of the esophagus with Barrett's metaplasia. This 
noninvasive point imaging system offers a method for obtaining real-time histological 
information during endoscopy. 
Objective: The objective of this study is to compare images taken with the fiber-optic 
endoscopic microscope with standard histopathology. 
Design: Feasibility study 
Setting: The University of Texas M.D. Anderson Cancer Center Department of 
Gastroenterology. 
Patients, Interventions, and Main Outcome Measurements: The tissue samples studied in 
this report were obtained by endoscopic resection from patients with previous diagnoses 
of either high grade dysplasia or esophageal adenocarcinoma. 
Results: Three distinct tissue types were observed ex vivo with the endoscopic 
microscope: normal squamous mucosa, Barrett's metaplasia, and high grade dysplasia. 
4
 The contents of this chapter have been previously published in Muldoon T, Anandasabapathy S, Mara D, 
and Richards-Kortum R. High-resolution imaging in Barrett's Esophagus: a novel, low cost endoscopic 
microscope. Gastrointest Endosc 2008; 68: 737-744. 
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Squamous tissue was identified by bright nuclei surrounded by dark cytoplasm in an 
ordered pattern. Barrett's metaplasia could be identified by large glandular structures 
with intact nuclear polarity. High grade dysplasia was visualized as plentiful, irregular 
glandular structures and loss of nuclear polarity. Standard histopathology of study 
samples confirmed the results obtained by the endoscopic microscope. 
Limitations: The endoscopic microscope probe had to be placed into direct contact with 
tissue. 
Conclusions: It was feasible to obtain high-resolution histopathologic information using 
the endoscopic microscope device. Future improvement and integration with wide field 
endoscopic techniques will aid in improving the sensitivity of detection of dysplasia and 
early cancer development in the esophagus. 
6.2 Introduction 
Barrett's Esophagus (BE) is characterized by the replacement of the normal 
squamous epithelium of the esophagus by a specialized, metaplastic columnar mucosa. A 
result of chronic gastroesophageal reflux disease, BE is significant because of a 
drastically increased risk for the development of esophageal adenocarcinoma (EAC). 
Indeed, subjects with BE carry a risk of EAC up to 125 times greater than the average 
person[127]. EAC itself is one of the most rapidly rising cancers in the United States 
having undergone a 5 to 10% increase in incidence per year over the last 30 years[128, 
129]. Despite increased awareness, survival rates for EAC remain a dismal 10-25%, an 
outcome largely due to diagnosis at an advanced stage. 
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In an effort to improve these statistics, much work has been focused on the early 
detection of EAC, through the diagnosis of high-grade dysplasia or minimally invasive 
(intramucosal) adenocarcinoma. However, the detection of this early neoplasia is 
technically challenging. On standard white-light endoscopy, dysplasia and early EAC are 
often focal, flat and difficult to consistently distinguish from regular metaplasia . 
Moreover, the current standard of esophagogastroduodenoscopy (EGD) with random, 4-
quadrant biopsies has been shown to miss nearly 2/3 of dysplastic lesions[130-132]. 
Therefore, there is a demand for minimally-invasive techniques which can detect 
dysplasia or cancer at an early stage. Such early detection will not only improve survival 
rates, but also facilitate the application of less-morbid alternatives to esophagectomy, 
such as endoscopic mucosal resection (EMR). 
Several recent optical technologies have sought to increase the detection of 
neoplasia, at both low and high-resolution. Among the lower resolution (so-called 
'widefield' technologies), autofluorescence endoscopy (AF) and narrow-band imaging 
(NBI) have been the best studied to date. While both of these modalities, have been 
shown to increase the detection of high grade dysplasia and early adenocarcinoma, 
specificity has not been impressive[133-139]. This is in part due to esophagitis and 
inflammatory confounders and other reactive epithelial alterations which can increase the 
number of false-positives. 
In order to improve upon current specificity rates among these new endoscopic 
imaging modalities, the use of complementary high-resolution technologies, capable of 
subcellular imaging, has been proposed. One of the most promising of these high-
resolution techniques is confocal endomicroscopy[140]. Indeed, a recent study by 
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Kiesslich et al. found high sensitivity and specificity rates for the detection of 
HGD/intramucosal EAC, when a confocal endoscope was used with fluorescent contrast 
agents [75, 141]. While use of such a device may be ideal in an academic or tertiary care-
setting where the prevalence of neoplasia is high, cost and the necessity for a separate 
system may preclude its translation to the community. Indeed, in a community-based, 
average-risk surveillance setting, a low-cost, probe-based device, compatible with any 
standard endoscope, may be preferable. 
In this paper, we describe a novel, low-cost imaging device developed in our 
laboratory. Our endoscopic microscope is based on the use of a flexible, small-caliber, 
fiber-optic image guide bundle. This fiber bundle, 1 millimeter in diameter, can be 
inserted into the biopsy channel of any standard endoscope, and is capable of 
fluorescence imaging at subcellular resolution[102]. Perhaps most appealing is the fact 
that the current prototype consists of less than $2500 in components and uses a 1-2 mm 
outer diameter probe which can be inserted into the biopsy channel of an endoscope, then 
sterilized and reused. This further reduces the cost of each application of the device, 
making it an ideal technology for community-based application. 
6.3 Patients and methods 
6.3.1 Patients 
Patients who participated in this study had been previously diagnosed with either 
high-grade dysplasia or intramucosal adenocarcinoma, and were scheduled for upper 
endoscopy with either jumbo biopsies or endoscopic mucosal resection (EMR) of the 
affected areas. The study protocols were approved by both the Rice University 
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Institutional Review Board and the University of Texas M.D. Anderson Cancer Center 
Institutional Review Board, and informed consent was obtained from each patient before 
the procedure. Eleven sequential patients with a documented history of Barrett's 
esophagus were approached for enrollment. One patient was excluded due to inability to 
perform the EMR (non-lifting); the remaining ten were imaged using the endoscopic 
microscope and topical acriflavine. 
For each patient, there were typically one to two samples obtained, and 
approximately 5 to 10 measurement sites on each sample. Images presented in this paper 
are typical for high quality specimens. 
6.3.2 Methods 
For this study, EMR specimens or 4 mm jumbo biopsies were obtained by a 
single endoscopist (S.A.) from patients with Barrett's dysplasia or esophageal 
adenocarcinoma. Optical images were obtained immediately after application of topical 
acriflavine (see Contrast Agent). Following imaging, the EMR samples and biopsies were 
submitted to a single expert GI pathologist (D.M.) for interpretation and the optical and 
histopathologic images reviewed. Over 100 optical images were obtained and reviewed. 
6.3.3 The Fiber Bundle Microscope 
The endoscopic microscope used in this study consisted of a 3 meter long image 
guide with 30,000 individual fibers. The spacing of the individual fibers largely 
determines the spatial resolution of the endoscopic microscope; in this case, the center-to-
center spacing was approximately 4 microns. The field of view of the system depends on 
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the diameter of the active area of the fiber bundle; in this case, a circular field of view 
with a diameter of 750 microns was produced. Images were produced by placing the 
distal surface of the fiber bundle into direct contact with the tissue to be interrogated. The 
image guide can be easily passed through the biopsy port of a standard endoscope (Figure 
6-1). Illumination was provided by a blue LED centered at 455 nm, which produced an 
illumination intensity of approximately 1 mW at the distal end of the fiber bundle. 
Fluorescent light returning through the bundle was directed to a scientific-grade CCD 
camera coupled to a PC. Images are displayed at a typical frame rate of 2 to 4 frames per 
second. The images presented in this paper appear as they would to a clinician viewing 
the monitor in a real-time setting. 
6.3.4 Fluorescent Contrast Agent 
Acriflavine hydrochloride was used as a topical contrast agent and was applied to 
tissues prior to imaging. Acriflavine has been shown to localize to the nuclei of cells, 
with minimal nonspecific cytoplasmic staining. A solution of 0.05% (w/v) acriflavine in 
buffered saline was applied with a cotton swab to the mucosa of each EMR specimen or 
biopsy prior to imaging. The acriflavine was placed on the specimen for 30 seconds, 
which was then rinsed with buffered saline to eliminate any unbound dye. Imaging was 
performed immediately following labeling. 
6.3.5 Criteria for interpretation of images 
The criteria applied to interpret endoscopic microscope images were based on 
differential histologic characteristics of tissue. These include well-established features 
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seen on light microscopy of standard histologic sections and previously published criteria 
for scanning confocal microscopy[141, 142]. The criteria used for light microscopy and 
confocal microscopy were utilized to identify the tissue type and evaluate the 
architectural and cytologic alterations. 
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Figure 6-1: Endoscopic Microscope. 6-la. Image of fiber bundle extending 
through the biopsy port of a standard white-light endoscope. 6-lb. Image of 
fiber bundle probe in vivo. 6-lc. Image of table-top endoscopic microscope; 
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fluorescence microscope unit is on the left, data-acquisition PC is on the right. 
6-Id. Schematic overview of the system. 
The non-neoplastic squamous mucosa is identified on histologic sections by its 
flat multilayered arrangement with polyhedral cell shapes, well defined cell membranes 
and centrally situated nuclei with regular internuclear distances. The invaginating lamina 
propria (papillae) are identified as extensions of lamina propria- composed of loose 
connective tissue with thin walled blood vessels- into the squamous epithelium at regular 
intervals. On confocal microscopy the cytologic characteristics of squamous epithelium is 
essentially identical to histology with polygonal cell shapes with well defined cell 
membranes and centrally situated nuclei; the latter two identified by their bright color as 
compared to the darker cytoplasm. Flat multilayering is assessed by the unaltered shape 
of the epithelial arrangement at progressively deeper optical sections of the mucosa. The 
papillae are identified as a circular dark area with the presence of scattered small bright 
structures corresponding to the connective tissue, red blood cells and inflammatory cells. 
The presence of intraepithelial inflammation is identified by inflammatory cells, which 
are seen as bright oval to round structures which are haphazardly distributed in the 
epithelium. 
Barrett's esophagus (intestinal metaplasia) is identified on histology by the 
presence of villiform architecture, columnar enterocytes and goblet cells. The criteria 
used for confocal microscopy includes the presence of round double layer ring (torus) 
structures which alter their shapes at different optical thicknesses. At deeper levels the 
ring-like structures show the classic villiform architecture. The villi are lined by the 
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columnar enterocytes with bight nuclei and dark cytoplasm. The lamina propria in the 
core of the villi shows a similar appearance to the squamous papillae with blood vessels 
and inflammatory cells. At cellular levels the presence of goblet cell is identified by clear 
to dark blue globules admixed with the columnar enterocytes. The border of the goblet 
cells is particularly bright in good quality images. In non-dysplastic Barrett's mucosa the 
intervillous stroma is abundant and identified by the presence of loose connective tissue, 
inflammatory cells and blood vessels. In highly dysplastic Barrett's mucosa the villous 
architecture is either effaced or completely lost. In addition, at different optical 
thicknesses the architecture is uniform with complex back-to-back arrangements of small 
glandular structures with minimal intervening stroma. The cytologic alterations, like 
multilayering of the cells, bright nuclear appearance, decreased goblet cells and high 
nuclear-to-cytoplasmic ratios are also applied to identify high-grade dysplasia. Another 
feature seen in good quality images is the structural relation of epithelium and 
subepithelial capillaries. In non dysplastic Barrett's mucosa the capillaries are regular and 
seen at upper and mid level thicknesses. However, in highly dysplastic mucosa the 
capillaries are seen only at deeper levels and show variations in size and shape. 
. Each image was analyzed independently and in a blinded fashion by both a 
gastrointestinal pathologist and a gastroenterologist. Endoscopic microscope images were 
then correlated with the standard histopathologic images, previously interpreted by the GI 
pathologist. 
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6.4 Results 
Images obtained with the endoscopic microscope were compared to 
histopathologic interpretation of the same areas. Fluorescence images were evaluated 
qualitatively, noting nuclear size and density, nuclear-to-cytoplasmic ratio, glandular 
structure and organization, and intensity of fluorescence. Distinct patterns of fluorescence 
images were observed for tissues with different histopathologic diagnoses: (1) normal 
squamous epithelium, (2) Barrett's metaplasia/low grade dysplasia, and (3) Barrett's 
neoplasia (high grade dysplasia or intramucosal adenocarcinoma). 
6.4.1 Normal squamous tissue 
Figure 6-2 shows histologic and endoscopic fluorescence microscopy images of 
normal squamous mucosa obtained from a site which appeared normal on white light 
endoscopy. The biopsy fragment was also imaged with a commercial fiber optic confocal 
endoscope (Pentax/Optiscan), and a standard commercial benchtop confocal system 
(Zeiss LSM 510 Meta). Both the fiber optic confocal system and the benchtop confocal 
microscope used an excitation wavelength of 488 nm. 
Individual cell nuclei are easily visible as discreet bright dots in fluorescence 
images obtained with the endoscopic microscope and the two confocal systems (Figure 6-
2). The field of view of the endoscopic microscope is much larger than the two confocal 
systems while the spatial resolution is somewhat decreased In addition, the frame rate of 
the endoscopic microscope (2 to 4 frames per second) is faster than that of the 
commercially available confocal endoscope (0.8 frames per second). The squamous 
epithelium is distinguished by its multilayering, polyhedral/polygonal shape and centrally 
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situated nuclei and well defined cell membrane. Uniform spacing of the nuclei indicates 
the intact polarity which distinguishes benign squamous mucosa. This also helps in 
differentiating other, more randomly distributed cells (e.g. inflammatory cells) which 
might infiltrate the epithelium. 
a. 
Figure 6-2: Images of normal squamous tissue. 6-2a. Endoscopic 
microscope image of normal squamous tissue stained with 0.05% 
acriflavine. 6-2b. Benchtop confocal (Zeiss LSM 510 Meta) image of 
same tissue. 6-2c. Pentax endoscopic confocal image of same tissue. 6-2a-
c show flat arrangement of squamous epithelium with round regularly 
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spaced nuclei. The round clear spaces surrounded by the epithelium 
represent the papillae (red arrowhead). The acriflavine in image 6-2a 
highlights the nuclei. 6-2d. Histopathology of same specimen. Scale bar is 
100 microns. 
6.4.2 Barrett's metaplasia 
Endoscopic microscope imaging was performed at several sites on EMR 
specimens labeled topically with acriflavine. Two sites are described in this paper (Figure 
6-3). The endoscopic microscope image in Figure 6-3a shows glandular epithelium 
characterized by double ring-like architecture with bright density distributed uniformly 
along the basement membrane consistent with intact nuclear polarity. In addition, the 
nuclei are uniformly distributed in the epithelium away from the basement membrane. 
These features are consistent with non-dysplastic glandular mucosa. 
The image in Figure 6-3b shows similar features as Figure 6-3a except for a small 
area of focal complex architecture, the significance of which is uncertain as the nuclear 
arrangement is that of non-dysplastic glandular epithelium described in Figure 6-3a This 
image is also consistent with Barrett's without dysplasia. The hematoxylin-eosin stained 
section of the same specimen in Figure 6-3c shows distinctive type Barrett's mucosa, 
histologically defined as intestinal metaplasia. The intestinal metaplasia is characterized 
by the presence of goblet cells, easily identified by intracytoplasmic clear-to-light blue 
vacuoles. These features are consistent with Barrett's metaplasia. 
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Figure 6-3: Images of Barrett's metaplasia. 6-3a. and b. Endoscopic microscope 
of Barrett's metaplasia stained with 0.05% acriflavine. Image 6-3a shows broad 
villous architecture. The bright band at the base of each villous-like structure 
indicates the high uptake of acriflavine by the nuclei (yellow arrowhead). Image 
6-3b shows larger torus-like structures with intervening stroma. Occasional goblet 
cells are highlighted by a marker (red arrowhead). 6-3c. Histopathology of same 
sample. Scale bars are 100 microns; all images at the same scale. 
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6.4.3 High grade dysplasia 
Endoscopic microscopy and histopathologic images taken from an EMR 
specimen with HGD are shown in Figure 6-4a and b, respectively. Figure 6-4a shows a 
confluent proliferation of small glandular structures with variable size and shape with 
occasional areas showing a gland-in-gland appearance. High nuclear density along with a 
large component of cells occupied entirely by nuclei indicate high nuclear-to-cytoplasmic 
ratio. These features are consistent with high-grade dysplasia. 
The hematoxylin-eosin stained section of the specimen shows distinctive type 
Barrett's mucosa with high-grade dysplasia, consistent with the features observed in the 
fluorescence image. The high-grade dysplasia is characterized by architecturally complex 
arrangement of the glands and loss of nuclear polarity, nuclear overcrowding, and nuclei 
and mitotic figures reaching up to the lumenal surface. 
Figure 6-4: Image of high-grade dysplasia. 6-4a. Endoscopic microscope 
image of high grade dysplasia stained with 0.05% acriflavine. Confluent 
and haphazard glandular proliferation with back-to-back arrangements 
and minimal to absent stroma. Foci of high nuclear intensity and high 
nuclear-to-cytoplasmic ratio are highlighted by markers (red arrowheads). 
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6-4b. Histopathology of same specimen. Scale bar is 100 microns; all 
images are at the same scale. 
6.5 Discussion 
This study demonstrates the ability of an inexpensive (< $2500) system with a 
reusable probe to produce high-resolution images of a variety of esophageal tissue types. 
Such a device can easily be integrated into any standard endoscope to non-invasively 
yield subcellular-resolution images of the surface histology of a suspected lesion with the 
use of an appropriate fluorescent dye. Coupled with wide-field imaging devices, this 
endoscopic microscope system should further enhance specificity for detection of 
Barrett's neoplasia. This low-cost device has advantages over more complex 'optical 
biopsy' systems because of its easy application to a wide variety of settings and 
platforms. The probe itself can be disinfected and reused, further reducing the cost of 
each use of the device. Moreover, the straightforward optical design is highly robust and 
requires no scanning mirrors or other moving parts, enabling such technology to 
disseminate to areas with high levels of support as well as regions with less infrastructure 
and resources. 
Non-invasive visualization of the cellular architecture enables a clinician to more 
thoroughly inspect the mucosa, and diagnose and treat intraepithelial neoplasia 
immediately. The strength of our study is the application of well-established, age-old 
pathologic criteria to interpret the optical images. Ideally, the real-time interpretation of 
such images will involve close collaboration between a gastroenterologist and GI 
pathologist. As has been shown with the interpretation of confocal endomicroscopic 
images, gastroenterologists can be trained to interpret optical images and distinguish 2 
pathologic classifications: Barrett's metaplasia/low grade dysplasia and Barrett's high 
grade dysplasia/intramucosal adenocarcinoma. A larger study with robust kappa statistics 
for interobserver reproducibility is planned for validation of this concept with this device. 
Additionally, work is underway to develop algorithms based on standard pathologic 
criteria (nucleancytoplasmic ratio, etc.) which can be translated into rapid, real-time, 
image-processing and interpretation software. 
From a clinical management standpoint, the diagnosis of Barrett's HGD or 
intramucosal adenocarcinoma is the most critical distinction. Given the large 
interobserver variability in the interpretation of low-grade dysplasia and the subtle 
architectural and morphologic features which characterize LGD, we feel that the 
identification of LGD may be beyond the capabilities of this technology. However, given 
the low likelihood of progression of LGD, we do not believe this is significant drawback. 
To further enhance the sensitivity and specificity of the technology for the detection of 
HGD/intramucosal cancer, we are currently working on combining high-resolution 
fluorescence imaging with other molecular-specific techniques (eq. optical contrast 
agents targeted to epithelial biomarkers). 
In order to achieve the high frame rates and good image quality seen in images 
from this device, selection of a bright, selective fluorescent dye is critical. Acriflavine 
hydrochloride, previously used as a topical antiseptic, was chosen for its ability to cross 
cell membranes and label acid molecules, including DNA. Acriflavine has been used in a 
number of European and Australian in vivo imaging studies of the gastrointestinal 
epithelium, as well as other studies, without any reported adverse effects[32, 75, 143, 
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144]. While acriflavine displays some affinity for collagen and elastin and some residual 
staining occurs in the cytoplasmic regions of cells, strong contrast is observed between 
cell nuclei and the surrounding cytoplasm. This enables qualitative observation of the 
cellular architecture of squamous and glandular patterns, as well as providing an estimate 
of nuclear-to-cytoplasmic ratios. Topical acriflavine also stains only the superficial layers 
of tissue, and has been shown to have limited effect below the lamina propria[75]. Since 
the contact imaging procedure used in the endoscopic microscope does not perform 
optical sectioning and does not reject fluorescent light as efficiently as a confocal 
microscope, superficial labeling improves image detail. 
There have been recent advances in the use of molecular-specific contrast agents. 
These agents consist of an optical reporter conjugated to a monoclonal antibody, aptamer, 
or other targeting ligand, and have been successfully implemented for the detection of 
abnormal expression levels of cell surface markers, including epidermal growth factor 
receptor (EGFR)[62]. These fluorescent contrast agents can be used with existing high-
resolution point imaging devices to yield both qualitative and quantitative data about the 
nature of neoplastic disease. In addition, the response of a particular tumor to a given 
therapy could be monitored over time in a non-invasive fashion. 
In conclusion, we have developed a low-cost fiber bundle-based high-resolution 
imaging system which is capable of visualizing cellular architecture, morphology, and 
nuclear-to-cytoplasmic ratios. Preliminary ex vivo evaluation shows that this system can 
differentiate between squamous mucosa, Barrett's metaplasia, and Barrett's 
intraepithelial neoplasia. Through the use of image processing techniques and 
segmentation of individual cell nuclei in images collected from the endoscopic 
microscope, it will be possible to provide a quantitative estimate of nuclear-to-
cytoplasmic ratios [102]. Future development and automation of such image processing 
software will lead to objective surveillance algorithms that can assist the endoscopist in 
locating dysplastic lesions. The use of such a translatable system in concert with existing 
and developing wide-field endoscopic technologies may facilitate improved specificity 
for the detection of Barrett's neoplasia and further clinical evaluation of this technology 
is forthcoming. 
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Chapter 7: Detection of esophageal adenocarcinoma and its 
precursors with a high-resolution microendoscope5 
7.1 Abstract 
Background and study aims: Early detection of dysplasia in patients with Barrett's 
metaplasia is essential to improved survival. The aim of this study was to evaluate the 
ability of high-resolution microendoscopic imaging to identify neoplastic lesions in 
patients with Barrett's esophagus. 
Patients and methods: Nine patients with previously diagnosed Barrett's esophagus with 
and without dysplasia underwent standard screening biopsies or endoscopic mucosal 
resection. Fresh tissue was imaged with the microendoscopy system; images were 
analyzed by visual interpretation or by quantitative image analysis to predict whether the 
imaged sites were non-neoplastic (Barrett's only or Barrett's with low grade dysplasia) or 
neoplastic (high grade dysplasia or esophageal adenocarcinoma). Predictions were 
compared to histopathology. 
Results: Subjective analysis of the images by a single expert clinician achieved sensitivity 
and specificity of 83% and 66%, respectively, while the quantitative classification 
algorithm achieved a sensitivity and specificity of 87% and 85%, respectively, when 
compared to histopathology. 
5
 The contents of this chapter are being prepared for publication. Timothy J. Muldoon, Nadhi Thekkek, 
Darren Roblyer, Dipen Maru, Sharmila Anandasabapathy, Rebecca Richards-Kortum are contributing 
authors. 
Conclusions: This pilot study demonstrates that a simple microendoscope device can 
yield clinically useful, objective information about the presence of neoplasia in patients 
with Barrett's esophagus. 
7.2 Introduction 
The incidence of esophageal adenocarcinoma (EAC) has increased six-fold in the 
United States over the past 30 years [145]. Cancer of the esophagus has one of the 
poorest overall five-year survival rates of all cancers. Reported five-year survival rates 
for patients with treatable esophageal adenocarcinoma are 14% and 0% for Stage II and 
IV disease, respectively [146]. Surgical treatment for locally advanced EAC is often 
invasive and carries significant risk. Early detection of disease is vital for improving 
long-term survival rates as well as the overall quality of life of affected patients. 
Traditional white light endoscopy does not provide sufficient information to 
detect the presence of very early dysplasia in regions of Barrett's metaplasia [147]. High-
resolution examination of tissue by histopathology is required; the current standard of 
care for surveillance of the esophagus following a diagnosis of Barrett's metaplasia 
involves taking four quadrant biopsies per centimeter over the length of the affected area. 
This sampling however, has been shown to have minimal effect on overall clinical 
outcome. [131, 132]. 
Recent advances in endoscopic examination techniques have shown promise in 
detecting dysplasia in Barrett's metaplasia, before the onset of invasive carcinoma. Wide 
field imaging techniques have the advantage of surveying large areas of mucosa during a 
single procedure. Narrow band imaging (NBI) is a technique which uses select regions 
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of the visible light spectrum which are favorably absorbed by hemoglobin [137, 138]. As 
a result, glandular and vascular patterns within a region of Barrett's metaplasia can be 
closely inspected for irregularities suggestive of early dysplasia. Another important new 
endoscopic imaging modality is autofluorescence (AF) visualization. In this technique, 
blue excitation light is used to illuminate the tissue, and long wavelength emission light is 
recorded by the imaging sensor [135, 148]. The autofluorescence signal contains 
information about the structure and biochemical components of the tissue, and is 
decreased in regions of dysplasia, allowing the clinician to survey large areas during a 
single examination. 
While these new methods have improved the rate of detection of adenocarcinoma 
in the gastrointestinal tract, they have demonstrated relatively poor specificity due to 
inflammation and other confounding factors [149]. To augment these techniques and 
improve the overall specificity of detection of EAC and its precursors, high-resolution 
imaging modalities can yield information at the cellular level, allowing the clinician to 
distinguish between dysplasia and inflammation or other reactive changes [150]. 
Confocal laser endoscopy (CLE) is an emerging technology which consists of a 
miniaturized single-fiber confocal microscope embedded in the distal end of a white light 
endoscope [31, 32]. CLE yields images with submicron resolution of the esophageal 
mucosa in real-time during an endoscopy procedure. This instantaneous feedback allows 
the clinician to directly examine in detail those regions that appear abnormal under wide-
field inspection. 
Complementary CLE with advanced wide field imaging techniques offers 
potential to improve early detection of dysplasia in Barrett's esophagus. However, at the 
present time, this technology is expensive and available primarily in tertiary care centers. 
In addition, CLE requires subjective interpretation of the images by the endoscopist, 
which requires extensive training and is subject to intraobserver variability [151-153]. 
To extend the benefits of high-resolution imaging to a broader patient population, and to 
create a more objective means of evaluating optical biopsy data, we developed a High-
Resolution Microendoscope (HRME) device that is capable of producing images of the 
esophageal mucosa at sub-cellular resolution without the need for expensive optics or 
scanning electronics . In a previous study of resected Barrett's tissue, HRME images 
could distinguish between non-dysplastic glandular architecture and dysplastic regions 
[103]. 
The goal of the study presented in this paper was to further explore use of the 
HRME system to distinguish between neoplastic and non-neoplastic Barrett's. Subjective 
analysis of HRME image data by expert clinicians was compared to an objective, 
computer-aided classification algorithm developed to differentiate Barrett's metaplasia 
from high grade dysplasia and cancer. 
7.3 Methods 
7.3.1 Patients 
Patients over 18 years of age with a previous diagnosis of Barrett's metaplasia of 
the esophagus and scheduled for surveillance endoscopy were asked to participate in the 
study. Informed consent was obtained from all study participants, and the study was 
reviewed and approved by the Institutional Review Boards at the University of Texas M. 
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D. Anderson Cancer Center and Rice University. Subjects underwent conventional 
endoscopy with standard four-quadrant biopsy surveillance; a subset of patients 
underwent endoscopic mucosal resection (EMR). Following resection, the biopsy or 
EMR specimens were taken to the lab for imaging. 
A solution of Proflavine (Sigma-Aldrich) dissolved in water at a concentration of 
0.01% (w/v) was prepared prior to performing imaging. The contrast agent solution was 
directly applied to the epithelial surface of the tissue with a dropper, and imaging with the 
HRME device was performed immediately. The application of proflavine does not 
discolor the tissue surface, and is not detectable in tissue slides prepared using standard 
histopathology processing and H&E staining (Figure 7-1). 
After imaging, the tissue was returned for standard histopathology processing, and 
slides were later reviewed by a board-certified pathologist (D.M.). Each measurement 
site used in this study was correlated to a histopathology-confirmed diagnostic category; 
Barrett's metaplasia without dysplasia, Barrett's with low grade dysplasia, Barrett's with 
high grade dysplasia, or esophageal adenocarcinoma. 
7.3.2 Imaging system 
The high-resolution microendoscope (HRME) device has been previously 
described in detail [102]. Briefly, images are acquired with this device by placing the tip 
of the fiber bundle image guide into direct contact with the epithelial surface of the tissue. 
Excitation light from a blue LED with a center wavelength of 455 nm is delivered 
through the fiber bundle. The fluorescence emission from the topically applied 
fluorescent contrast agent, proflavine, is collected through the fiber bundle, focused onto 
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a CCD camera, and a digital image is stored for future processing and analysis. The 
HRME system has a circular field of view with a diameter of 750 microns; the lateral 
spatial resolution of the system is approximately 4 microns, and images are displayed at 4 
frames per second. 
7.3.3 HRME Image Analysis 
Digital HRME images were reviewed to determine whether the endoscope tip was 
in contact with the tissue surface or whether the probe tip moved during image 
acquisition. Images showing such artifacts were discarded and not used in subsequent 
analyses. 
Digital HRME images passing quality control were reviewed by two expert 
pathologists and two expert gastroenterologists. The reviewers were shown the images 
from the entire data set following randomization. Each was asked to score the images as 
either "neoplastic" or "non-neoplastic," where "non-neoplastic" corresponds to a 
pathologic diagnosis of Barrett's metaplasia or Barrett's metaplasia with low grade 
dysplasia, and "neoplastic" corresponds to Barrett's metaplasia with high grade dysplasia 
or EAC. Results of visual image interpretation were compared to the histopathology-
confirmed diagnosis at each site, and sensitivity and specificity were calculated for each 
observer. The kappa statistic was also computed to measure the inter-observer agreement. 
In addition to subjective image interpretation, we explored the diagnostic ability 
of quantitative image analysis. For each image, fifty-nine distinct features were 
computed (Table 7-1). First order statistical features (variance, entropy, etc.) were 
calculated directly from the raw pixel values. A gray-level co-occurrence matrix 
(GLCM) with pixel offsets from 1 to 10 was used to calculate additional textural feature 
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groups (correlation, contrast, homogeneity, and energy) [108]. Each GLCM feature group 
contained 10 distinct features, corresponding to each pixel offset. To detect nuclear 
features, an extended regional maximum transform was applied to the image. Voronoi 
tessellations were calculated from the centroids of the nuclear features to calculate 
internuclear distances [85]. A Fourier transform was applied to each image to calculate 
the power spectrum; this was divided into 10 partitions to represent the frequency 
components of the image. The contribution of each partition is represented as a fraction 
of the total power spectrum [109, 110]. 
A diagnostic algorithm was developed to classify each image as non-neoplastic or 
neoplastic using these image features as input. Histopathology again was used as the 
gold standard; sites with a pathologic diagnosis of Barrett's metaplasia or Barrett's 
metaplasia with low grade dysplasia were considered to be non-neoplastic, while sites 
with a pathologic diagnosis of Barrett's metaplasia with high grade dysplasia or 
esophageal adenocarcinoma were considered to be neoplastic. The classifier was based 
on two-class, linear discriminant analysis; a sequential forward feature-selection 
algorithm initially was used to select the best performing subset of up to 10 image 
features to classify the data. Initially, the best performing single feature was identified, 
and then subsequent features were selected which gave maximum performance when 
combined with previously selected features. The algorithm was developed using five-fold 
cross-validation; each measurement site was initially randomly assigned to one of five 
groups. Four-fifths of the data were then used to train the linear classification algorithm 
and the remaining one fifth of the data were used to test the algorithm. This cycle was 
repeated four additional times so that the algorithm is tested using data from each site. 
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Performance was monitored by calculating the area under the curve (AUC) of the 
classifier. 
Alternatively, a three-class diagnostic algorithm was developed to classify each 
image as: (1) Barrett's metaplasia or Barrett's metaplasia with low grade dysplasia, (2) 
Barrett's metaplasia with high-grade dysplasia, and (3) cancer. A categorical tree-based 
classifier was used. This algorithm was allowed to choose among the entire feature set 
[111, 112]. The tree-based classifier was pruned to three terminal nodes to avoid 
overtraining; two features were selected to perform this step. The predicted classification 
results from each classifier were then compared to the actual histopathology for each site. 
7.4 Results 
7.4.1 Patients and measurement sites: 
Nine subjects enrolled in the study. Images were obtained from 139 unique sites; 
images from 128 of these sites passed the QC review and were used for further analysis. 
Of these 128 sites, 6 were histologically confirmed to be Barrett's metaplasia, 53 were 
Barrett's with low grade dysplasia (LGD), 26 were Barrett's with high grade dysplasia 
(HGD), and 43 were esophageal adenocarcinoma (EAC). Figure 7-1 shows representative 
HRME images (top row) and corresponding histopathology (bottom row) of non-
neoplastic (LGD), HGD, and EAC, respectively. All images are at the same scale for 
comparison. Large, well-organized glands can be seen in the non-neoplastic Barrett's 
case, while smaller glands with disrupted boarders are visible in the HGD case. The 
I l l 
image of EAC shows extreme disruption of glandular organization and crowded, 
abnormal cells. 
Barrett's metaplasia with High grade dysplasia Esophageal adenocarcinoma 
low grade dysplasia 
Figure 7-1: Illustration of HRME images (top row) compared to H&E 
images (bottom row). From right to left, diagnostic categories are: 
Barrett's metaplasia with low grade dysplasia (LGD), high grade dysplasia 
(HGD) and esophageal adenocarcinoma (EAC). All images are sized to 
the same scale; scale bar represents 100 um. 
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7.4.2 Subjective image interpretation: 
Subjective scoring of the images by an expert gastroenterologist (S.A.) achieved a 
sensitivity of 83% and specificity of 66%. 
7.4.3 Quantitative image feature calculation 
Quantitative image features were ranked according to their diagnostic ability. 
Image features in Table 7-1 are listed in order of descending area under the ROC curve 
for the single-feature, two-class linear discriminant analysis classifier. The single best 
performing feature was found to be the GLCM correlation with a pixel offset of 10. 
Figure 7-2a shows a box plot representing the GLCM correlation values, averaged for 
each of three major diagnostic categories: Barrett's and LGD, HGD, and EAC. On 
average, the GLCM correlation level is lower in sites with HGD or EAC when compared 
to non-neoplastic sites. 
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Feature 
Correlation (10 features) 
Standard Deviation 
Variance 
Energy (10 features) 
Frequency (10 features) 
Entropy 
Mean Nuclear Separation 
Distance 
Std. Dev. Nuclear 
Separation Distance 
Nuclei Per Unit Area 
Kurtosis 
Skewness 
Contrast (10 features) 
Homogeneity (10 features) 
Mean Minimum Nuclear 
Separation Distance 
Explanation 
Pixel neighbor correlation over the entire image 
Standard deviation of grayscale values 
Variance of pixel grayscale values 
Sum of squares in gray-level co-occurrence matrix (GLCM) 
Frequency distribution of pixel values 
Statistical measurement of randomness of grayscale values 
Mean nuclear separation as calculated by Voronoi tessellation 
Standard deviation of nuclear separation as calculated by Voronoi 
tessellation 
Number of nuclei detected divided by area of region of interest 
Measure of the flatness of the pixel value distributions 
Measure of the symmetry of the pixel value distribution 
Measure of pixel intensity compared to its neighbors over the 
entire image 
Closeness of the distribution of the GLCM elements to the diagonal 
Average minimum nuclear separation as calculated by Voronoi 
tessellation 
Table 7-1: Quantitative image features. The table is in order of performance as 
roughly estimated by a linear discriminant analysis using one feature and the 
entire data set for training and testing. 
The top performing combination of two features was found to be the GLCM 
correlation value at an offset of 10 and the frequency contribution at an offset of 6; this is 
the relative contribution to the total power spectrum coming from the frequencies over 
the 6th partition from the Fourier transform. Figure 7-2b shows a scatter plot of these two 
features for each of the 128 sites in the data set. Samples with a pathologic diagnosis of 
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Barrett's with or without LGD are shown as blue squares, while samples with a 
pathologic diagnosis of HGD or EAC are shown as red crosses. The decision line 
calculated using a two-class linear discriminant classifier is shown on the plot. 
Figure 7-3a shows the area under the curve as a function of the number of image 
features selected in the linear discriminant algorithm. The AUC increases from one to 
two features and reaches a plateau. Figure 7-3b shows a scatter plot of the posterior 
probability that each site is neoplastic (HGD or EAC) as calculated by the linear 
classifier; samples are grouped by histopathologic diagnosis. Figure 7-3c shows the 
ROC curve for the linear discriminant classifier based on these two features. The AUC is 
0.92 and the sensitivity and specificity at the Q-point are 87% and 85%, respectively. 
The tree-based three-class classifier used automated feature selection. The 
features chosen by this algorithm were again GLCM correlation and frequency 
contribution. Table 7-2 summarizes the performance of the three-class algorithm; vertical 
columns add to 100%, to indicate the proportion of predicted measurements that were 
placed into the correct category. The tree-based classifier performed very well in 
distinguishing the non-neoplastic case (93.9%) and when predicting HGD and EAC 
(73.1% and 75.5%, respectively). 
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Figure 7-2: Quantitative analysis. 7-2a. Box plot showing the classification 
utility of GLCM correlation as a single feature. Note the separation between 
Barrett's metaplasia and LGD compared to HGD and EAC. 7-2b. Measurement 
sites plotted using two features. Non-neoplastic sites are plotted as blue squares, 
neoplastic sites are plotted as red crosses. The decision line is shown. 
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7.5 Discussion 
In this study, we demonstrated the use of a simple, low-cost portable 
microendoscopy system to distinguish between clinically significant classes of intestinal 
metaplasia, dysplasia and cancer. Subjective image interpretation and an operator-
independent image analysis algorithm were both used to differentiate between these 
categories. Subjective image interpretation demonstrated sensitivity and specificity of 
83% and 66%, respectively. The objective classification algorithm was able to distinguish 
between neoplastic and non-neoplastic cases with a sensitivity of 87% and a specificity of 
85%. The results of this pilot study are suggestive that this technique may be useful to 
regions without highly trained expert personnel or extensive biomedical infrastructure. 
Three-Class Tree-Based Classifier Results 
IM/LGD Actual 
HGD Actual 
EAC Actual 
IM/LGD Predicted 
93.9 
4.1 
2.0 
HGD Predicted 
19.2 
73.1 
7.7 
EAC Predicted 
13.2 
11.3 
75.5 
Table 7-2: Summary of the performance of the tree-based three-class classifier. 
As with any small pilot study, a larger sample size will be required to improve the 
significance of the classification algorithm presented here. Specifically, a large, 
independent test set should be validated using the algorithm following training on a 
separate training data set. Such large data set validation will reduce the influence of 
overfitting of the classification algorithm and yield more reliable performance values. 
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Figure 7-3: Classification performance. 7-3a. Calculated classification 
performance versus number of features used; note the plateau at two 
features. 7-3b. Scatter plot of calculated posterior probability generated by 
a two-feature linear discriminant analysis (LDA) algorithm. The decision 
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is shown at 0.24. 7-3c. ROC curve of calculated classification 
performance using the two-class, two-feature LDA. The Q-point is shown 
corresponding to a sensitivity of 87% and a specificity of 85%. 
An additional limitation of this trial is the HRME probe's inability to image 
subsurface regions. While the incidence of high-risk submucosal or occult EAC is still 
subject to controversy, inspection of subsurface regions remains an important 
consideration to clinicians [154]. The current HRME device yields images by placing the 
tip of the device into direct contact with tissue, limiting its image acquisition to the top 
layers of epithelium. However, the fiber optic probe is small enough to pass through the 
lumen of a 16-gauge needle; the needle could be used to physically penetrate into deeper 
layers of the epithelium, allowing the fiber bundle to image these areas. This technique 
has been successfully demonstrated in a mouse model. 
High-resolution imaging of the gastrointestinal epithelium offers clinicians a 
means to inspect the histologic features of suspicious lesions and post resection margins 
in real time during an endoscopic procedure. Such information can be used to guide the 
selection of sites for biopsy to improve the diagnostic yield during screening endoscopy 
[155]. Traditional CLE typically requires the endoscopist to interpret images during the 
procedure. This subjective interpretation is likely highly dependent on clinician training, 
and is variable by its subjective nature. A more objective means of image interpretation 
may help guide the endoscopist's decision as to the classification of a lesion. Such 
objective image analysis has been applied in other high-resolution imaging studies; 
Becker et al. demonstrated that computer-aided diagnosis of mucosal pit patterns but a 
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fiber bundle confocal system has been shown to be effective in distinguishing neoplastic 
from non-neoplastic Barrett's tissue [100]. 
The image processing techniques presented in this study can uncover features in 
images that are clinically important, but which may not be apparently to the clinician 
performing the procedure. In addition, quantitative image analysis and classification 
techniques require relatively minimal computing time, which is useful in a busy clinical 
setting. The HRME system and classification algorithm presented in this paper represent 
a low-cost system that is easily integrated into currently used endoscopy systems and can 
be operated independent of the clinician's subjective interpretations of images. 
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Chapter 8: Discussion 
8.1 Summary of Findings 
The results of the preceding studies have demonstrated that a simple, fiber bundle 
image guide-based microendoscopy system is capable of employing a number of 
fluorescent contrast agents in collecting high-quality, high-resolution images of both in 
vitro cell phantoms, in vivo imaging of small animal tissues, and imaging several types of 
resected human tissue epithelium. Quantitative image processing techniques and 
objective classification algorithms were also used to help aid in classifying measurement 
sites in human epithelium as neoplastic or non-neoplastic, a clinically important 
distinction. 
Initial studies presented in Chapter 3 measured the performance of the device, 
including using a USAF reolution target to verify that the HRME could resolve 4 micron 
lines. Biological models were then used with the system to demonstrate its flexibility; 
molecular-specific antibody and quantum dot labeling schemes were successfully used to 
image cells overexpressing cell surface receptors, including Her-2 and EGFR receptors. 
A murine tumor xenograft explored the in vivo and small animal imaging capabilities of 
the device, using a hypodermic needle as a guide to place the fiber bundle into the 
subcutaneous tumor and evaluate its structure at subcellular resolution. Finally, initial 
imaging results from resected human oral mucosa were presented. 
Chapter 4 presents a quantitative means of analyzing microendoscope images of 
the oral epithelium. Images from resected specimens from 13 patients, comprising 141 
independent, histopathology-confirmed measurement sites were analyzed for numerical 
features. These features included first-order statistics, including pixel gray value variance 
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and entropy, texture features calculated by a gray-level co-occurrence matrix, frequency 
components, and nuclear features, such as inter-nuclear spacing. These features were 
used to train and evaluate a linear discriminant algorithm to classify images into 
neoplastic (invasive cancer, severe and moderate dysplasia) or non-neoplastic (normal 
squamous or mild dysplasia) categories. The sensitivity and specificity performance for 
this algorithm was 85% and 78%, respectively. Chapter 5 presents a quantitative 
combinatorial method that incorporates HRME data with wide field autofluorescence 
imaging data into a classification algorithm, to demonstrate how different imaging 
modalities, providing fundamentally different information. Various combination methods 
are used to train and validate the classification algorithm, which used both a linear 
discriminant analysis as well as a classification tree method. The best-performing 
combinatorial method, which involved weighting the contributions from both systems, 
yielded a performance gain of better than 10% over the performance of any one system 
alone. 
Chapter 6 demonstrates that the HRME system can be used on a distinctly 
different tissue type. Barrett's metaplasia involves the transformation of the normal 
squamous epithelium of the esophagus to a glandular, intestinal type. This change is not 
neoplastic in itself, but malignant transformation can occur in a small fraction of cases. 
HRME images of this glandular tissue is able to reveal the presence of large, intact glands 
in non-neoplastic cases, while neoplastic tissue clearly shows disrupted, overlapping 
glands, or loss of glandular structure altogether. Quantitative image analysis, presented in 
Chapter 7 and using the same feature analysis tools introduced in Chapter 4, can also 
successfully classify images as neoplastic or non-neoplastic. A study of ex vivo 
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esophageal tissue from 9 patients, comprised of 128 independent pathology-confirmed 
measurement sites yielded a classification performance of 87% sensitivity and 85% 
specificity. 
8.2 Implications 
High-resolution imaging for cancer diagnostic applications is an emerging field 
that has benefitted significantly from recent advances in fiber optic, computer, and 
microelectromechanical systems (MEMS). Sophisticated endomicroscopy systems allow 
imaging of epithelial tissue in organ systems that are not readily available, such as the 
bronchi, esophagus, and colon[31, 32, 100, 101]. These "optical biopsy' techniques yield 
important structural information at subcellular resolution that was typically only obtained 
with histopathology and physical removal of the tissue. This is of particular importance in 
gastrointestinal imaging, where the tissue epithelium is only accessible through a 
specialized endoscopy system. Providing feedback during such endoscopy procedures 
could help guide therapeutic applications. 
While high-resolution imaging systems have been miniaturized as to directly 
access the oral cavity, or directly integrated into endoscopy systems, complex scanning 
electronics and laser illumination systems remain expensive. The development of the 
HPvME presented in this dissertation was motivated by the need to reduce costs and 
improve reliability so such technology could be more easily disseminated to regions with 
less sophisticated infrastructure. While this system sacrifices lateral resolution and axial 
sectioning, as is possible in systems with confocal capabilities, image quality is sufficient 
to discriminate between clinically significant disease states. Using an appropriate 
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fluorescence contrast agent that is responsive to changes that occur in dysplasia is 
essential. Proflavine, a DNA-intercalating dye that crosses the cell membrane without the 
need for any specialized buffer solutions, yields excellent nuclear contrast. Since many 
of the hallmark structural changes that occur in dysplasia are visible in the nucleus, 
proflavine is an ideal contrast agent complement to the HRJV1E system. 
Since the images taken by the HRME are digitally stored, quantitative image 
processing and analysis techniques were of great importance in these studies. Analyses of 
textural features in the images were of particular use in distinguishing between neoplastic 
and non-neoplastic measurement sites. This is due in large part to the nuclear localization 
of the proflavine molecule; since dysplastic changes tend to occur in cell nuclei, and the 
majority of the fluorescence emission light collected by the HRME was from nuclear-
localized proflavine, text image analysis is a logical means to differentiate between these 
two states. Difficulties in this technique arise when proflavine is sequestered in regions of 
the epithelium that do not contain cell nuclei, such as a thick keratin layer on the surface 
of the tissue. 
Of particular interest in this study is the use of the HRME device and image 
classification techniques to study different tissue types- squamous mucosa (oral 
squamous cancer studies) and columnar mucosa (Barrett's neoplasia studies). Dysplasia 
of squamous mucosa is characterized by increasing nuclear crowding and nuclear atypia, 
while dysplasia in columnar epithelium is characterized by crowded and disrupted gland 
structure. Although the same image features were not selected by the classification 
algorithm code, textural features again played a large role. The ability to use the same 
device and computer-based classification tools in both tissue types demonstrates the 
flexibility of the technique and its potential as an optical diagnostic tool. 
8.3 Future Work 
In order to increase the flexibility of the HRME device, and to further explore 
high-resolution imaging with molecular-specific contrast agents, coupling an additional 
light source to the system is a logical future project. The blue LED module that is 
currently used could be retained to enable the continued use of proflavine, perhaps as a 
nuclear counterstain, but its wide bandwidth would require the additional light source to 
be in the red region of the spectrum. Reduced cost and portability were original design 
considerations for the HRME; the availability, low cost, and low power requirements of 
laser diodes makes them an ideal choice. Organic dyes, such as Alexa-647 (Invitrogen, 
Carlsbad, CA) have been shown to be easily conjugated to monoclonal antibodies, 
enabling HRME imaging of cell surface markers with molecular specificity. A laser 
module with a 633nm line would be capable of exciting this Alexa-647 fluorophore; an 
appropriate dichroic mirror and long pass filter could be placed as a secondary detection 
arm in the existing HRME system, while replacing the folding mirror with a dichroic 
with long-wavelength transmission in the current detection arm. 
Due to the promising results of the quantitative oral mucosa and Barrett's 
metaplasia projects, it would be interesting to perform similar analyses on various other 
human epithelial tissue. Bronchial tissue, the biliary tree, and other lumenal organs are 
other important sites that the HRME could image. However, due to the location in the 
body, reaching some of these sites may prove difficult, though current bronchoscopy and 
ERCP systems may offer a means of introducing the fiber optic probe to the regions to be 
imaged. 
As previously mentioned, image artifacts are introduced when non-specific 
binding of the proflavine contrast agent occurs. Proflavine has some affinity for keratin 
and collagen, for example, with the former being present in a large subset or oral lesions. 
To overcome this effect, it would be beneficial for the fiber optic probe to be 
mechanically coupled to a hypodermic needle device. While a simple version of this was 
demonstrated in Chapter 3 on a murine model, a smaller and more precise system could 
be developed for human oral epithelium. Beveling the end of the image guide may prove 
useful for mechanically penetrating tissue, though this would come at a cost of some 
lateral resolution. 
Another significant future project for the HRME device is to collect a large 
validation set for both of the quantitative imaging studies presented here. These larger-
scale studies could benefit from distributing several HRME devices to multiple centers. 
In addition, recent approval by the Food and Drug Administration of an Investigational 
New Drug application for proflavine enables the possibility of collected this validation 
set on in vivo tissue. This information would be of great importance in establishing the 
HRME technology as a useful diagnostic screening tool. 
8.4 Conclusion 
This dissertation has demonstrated the use of a simple and robust fiber bundle 
image guide based microendoscopy system. This microendoscope was validated using 
non-biologic targets as well as in vitro cell culture, including a demonstration of 
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molecular-specific labeling. The device was also used in small animal and human tissue 
studies. A quantitative classification algorithm was developed that demonstrating the 
ability of the device to objectively differentiate between non-neoplastic tissue and 
clinically significant disease. This technology has the potential to be distributed to a wide 
range of medical settings, and not limited to tertiary-care centers. Widespread use of the 
HRME system as a complement to existing screening techniques, or as an intra-operative 
margin detection tool should aid in earlier detection of neoplastic change in precancerous 
lesions of human epithelial tissue, improving the number of tissue-sparing treatment 
modalities and reducing associated morbidity. 
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